Staff Profile
Emeritus Professor Robert Perry
Emeritus Professor
- Email: [email protected]
- Address: Biomedical Research Building
Campus for Ageing and Vitality
Newcastle University
Newcastle upon Tyne NE4 5PL
MB ChB (St Andrews), DSc (Newcastle), MRCP Edin (Cardiology), FRCP Edin & Lond, FRCPath (Histo & Neuropathology)
DSc - Clinical, Neuropathological and Neurochemical studies in Dementia with Lewy Bodies, Parkinson's disease, Down's syndrome, Schizophrenia & Depression
Reader Neurochemical Pathology 1994-2009
Professor of Neuropathology 1998-2009, Emeritus 2009
Kellog International Scholar 1984 (USA)
Appointments:
Dundee Royal Infirmary 1969 (HS)
Leicester Royal Infirmary & Groby Road Hospital - General Medicine, Neurology, Cardiology, Respiratory Medicine and Infectious Diseases 1970-72; HP, SHO, Registrar
Newcastle General Hospital 1972-2009 Neurosurgery & Neuropathology; SHO, Registrar, SR, Consultant
MRC Neuroendocrinology Unit 1980-1985 Clinical Scientist and Hon Neuropathologist
Consultant Neuropathologist 1986-2009
Principal Fields of Neuroscience interest:
Newcastle Brain Tissue Resource (NBTR) / Brain Bank: established the NBTR in Neuropathology Department (1975), extended to MRC Unit 1981. Use of postmortem and biopsied fixed and frozen human brain tissue for combined clinical diagnosis, research, quantitation, and genetic studies - both in Newcastle for national and international collaborative research. Established initial parameters for sampling and freezing brain tissue, including characterization of human brain and organ temperatures after death, slow versus rapid brain freezing techniques, influence of circadian variations (with Elaine Perry - EKP), optimum brain removal and dissection conditions, optimum dissection techniques for freezing and fixing dissected human brain, novel macro- and microchemical dissection techniques, optimal preparation of synaptosomes (with John Hardy), enzyme histo and immuno-histochemical parameters.
Human Brain Dissection Guide devised as an idealized Brodmann Area Coronal Brain Map with identification of individual slices (33 total) identified by internal brain landmarks and frontal/occipital pole ratios (with Arthur Oakley and Mary Johnson); Development of Large Format Cryostat (with John Candy - JC) for study of whole brain slices - including modifications to Brights cryostat machinary; Microanatomical dissection for neurochemistry of Nucleus of Meynert and Amygdaloid using micropunches adapted from neurosurgery, and neurochemistry of neocortical layers using supercooled liquid nitrogen and cortical column preservation; MRI in postmortem brain tissue - coronal slices and whole hemispheres - initial studies with Philip English (Dept of Radiology NGH) - subsequent research combined with Professor John O'Brien and Professor Paul Ince;
Dementia in the Elderly: Initial studies in Alzheimer' disease (with Bernard Tomlinson - BET & EKP) were extended in 1980 to Parkinson's disease (PD) without and PD with dementia (PDD), normal elderly showing "incidental" Lewy bodies: identification of clinical, pathological, and neurochemical features of Dementia with Lewy Bodies (DLB) and its differentiation from PD and PDD using neuropathological, clinical features (case note analysis of psychiatric and cognitive features), and histo/neurochemical, parameters [autopsies on patients dying in psychiatric and neurologic institutions - principally referred by Garry Blessed (GB) Andrew Fairbairn (AF) and colleagues, and Neurologists, pathologists and general physicians = controls patients]. Initially termed 'Atypical dementia' (1980-88) and SDLT (Senile Dementia of Lewy Body Type 1988-95) DLB was differentiated from cases of Alzheimer's Disease (AD), PD, PDD, Diffuse Lewy Body Disease (DLBD), and 'incidental' Lewy body formation in normal elderly. In PD a significant number of cases had a dementing syndrome, and a cholinergic deficit was reported in both PD and PDD, and patients dying with PDD noted to have either no or a variable amount of Alzheimer pathology usually not amounting to concomitant Alzheimer's disease. "Incidental" Lewy body disease in the normal elderly (<3% in 135cases) was found at least 50% below that previously reported. These first reports of DLB (1988 to 1992 - combined with PDD = Lewy Body Dementia - LBD) lead to an International symposium on DLB in Newcastle in 1995 - jointly organized by RP, Elaine Perry and Ian McKeith (Clinical Psychiatrist from 1992, GB retired in 1988) and the first (and subsequent) Report of the DLB Consortium.
Alzheimer's Disease (AD) and DLB Neurochemistry (with EK Perry) identification of cholinergic deficiet, biochemical and histochemical observations; quantitation of cholinergic parameters of Nucleus of Meynert neurone loss in AD and PD and DLB, Neurotransmitter and Receptor analysis, including autoradiography of hemispheric brain slices; identification of serotonergic, monoaminergic, and gabergic deficits in normal elderly and dementia. Frontotemporal Dementia (FTD) research (including the youngest case report), and recognition of clinical, pathological, and neurochemical features of a change in FTD phenotype expression in the elderly (over 65/70years) including memory loss and clinical differentiation from cases clinically classified as 'atypical AD'. Neurofilament Inclusion Disease (NID) first identification of the entity Intermediate Neurofilament Disease. and later reports with national and international colleagues. Mitochondrial Diseases histollogical, quantitative and Immunohistochemical observations on the brains of patients with mitochondrial disorders - with Evelyn Jaros (EJ), D Turnbull, P Chinnery; case and other reports on Mental deficiency, Paediatric neurological disorders, autism, Factor X deficiency, Depression
Related Neuroscience Research: Fibrillary forms of small neuropeptides initiation of research and identification using electron microscopic techniques (with Arthur Oakley, Peter Sherwood, John Candy, and EKP); subsequent physiological studies (AEO JC J Boakes); Neuroanatomical cholinergic studies during human brain development - with JC, EKP- Nucleus of Meynert; amygdala; Identification of Peptidergic nuclei and Tracts in the human brain with JC and physiology colleagues; Tumour Research and Paediatric Neurooncology with Andrew Pearson, EJ, Dr Lunec; Pituitary Tumours - peptidergic content; Schizophrenia; Huntington's Chorea; Down's Syndrome identification of elderly cases of elderly cases with minimal Alzheimer-type pathology and no obvious development of clinical features of dementia; identification of a subset of DS cases with Lewy body formation in the brainstem and cerebral hemispheres (with colleagues GB, CKN, BB (Prudhoe Hospital), Dr K Day (Northgate Hospital); and after 1986 collaboration with Professor D Kay, Dr S Tyrer, and colleagues.
Neuropathology and associated tuition to medical students, students, trainees, and colleagues.
-
Articles
- Hase Y, Polvikoski TM, Firbank MJ, Craggs LJL, Hawthorne E, Platten C, Stevenson W, Deramecourt V, Ballard C, Kenny RA, Perry RH, Ince P, Carare RO, Allan LM, Horsburgh K, Kalaria RN. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction. Brain Pathology 2020, 30(1), 191-202.
- Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, De Jager P, Schneider JA, Morris CM, McKeith IG, Perry RH, Lovestone S, Woltjer RL, Beach TG, Sue LI, Serrano GE, Lieberman AP, Albin RL, Ferrer I, Mash DC, Hulette CM, Ervin JF, Reiman EM, Hardy JA, Bennett DA, Schadt E, Smith RD, Myers AJ. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 2018, 141(9), 2721-2739.
- Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β Normal 0 false false false EN-GB X-NONE X-NONE -amyloid load. Neurology 2015, 84(5), 496-499.
- Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DMA. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathology and Applied Neurobiology 2015, 41(5), 601-612.
- Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Bohr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology 2013, 72(1), 53-60.
- Davidson YS, Robinson AC, Hu Q, Mishra M, Baborie A, Jaros E, Perry RH, Cairns NJ, Richardson A, Gerhard A, Neary D, Snowden JS, Bigio EH, Mann DMA. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes. Neuropathology and Applied Neurobiology 2013, 39(2), 157-165.
- Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012, 78(14), 1043-1050.
- Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT. Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia. International Journal of Geriatric Psychiatry 2012, 27(12), 1267-1274.
- Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease 2012, 47(2), 155-162.
- Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG. Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology 2012, 38(4), 344-353.
- Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Frontotemporal Dementia in Elderly Individuals. Archives of Neurology 2012, 69(8), 1052-1060.
- Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IRA, Perry RH, Skullerud K, Yokoo H, Cairns NJ. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathologica 2011, 121(2), 219-228.
- Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, Momeni P, Baborie A, Griffiths TD, Jaros E, Perry RH, Richardson A, Pickering-Brown SM, Neary D, Mann DMA. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathologica 2011, 122(1), 99-110.
- Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IR, Perry RH, Skullerud K, Yokoo H, Cairns NJ. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID). Journal of Neurotransmiission 2011, 118(11), 1651-1657.
- Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis D, Pal P, Rollinson S, Pickering-Brown S, Thompson JC, Neary D, Snowden JS, Perry R, Mann DMA. Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathologica 2011, 121(3), 365-371.
- Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK. Neurogenic Marker Abnormalities in the Hippocampus in Dementia with Lewy Bodies. Hippocampus 2011, 21(10), 1126-1136.
- Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL. Increased neural progenitors in vascular dementia. Neurobiology of Aging 2011, 32(12), 2152-2161.
- Page T, Gitcho MA, Mosaheb S, Carter D, Chakraverty S, Perry RH, Bigio EH, Gearing M, Ferrer I, Goate AM, Cairns NJ, Thorpe JR. FUS Immunogold Labeling TEM Analysis of the Neuronal Cytoplasmic Inclusions of Neuronal Intermediate Filament Inclusion Disease: A Frontotemporal Lobar Degeneration with FUS Proteinopathy. Journal of Molecular Neuroscience 2011, 45(3), 409-421.
- Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du-Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica 2011, 122(1), 111-113.
- Elstner M, Morris C, Heim K, Lichtner P, Bender A, Mehta D, Schulte C, Sharma M, Hudson G, Goldwurm S, Giovanetti A, Zeviani M, Burn D, McKeith I, Perry R, Jaros E, Krüger R, Wichmann H, Schreiber S, Campbell H, Wilson J, Wright A, Dunlop M, Pistis G, Toniolo D, Chinnery P, Gasser T, Klopstock T, Meitinger T, Prokisch H, Turnbull D. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Annals of Neurology 2009, 66(6), 792-798.
- Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. Journal of Neurology 2009, 256(5), 717-720.
- Betts-Henderson J, Jaros E, Krishnan KJ, Perry RH, Reeve AK, Schaefer AM, Taylor RW, Turnbull DM. Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Neuropathology and Applied Neurobiology 2009, 35(1), 120-124.
- MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. Journal of Neural Transmission 2008, 115(6), 869-878.
- Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT. Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson's Disease Dementia. Dementia and Geriatric Cognitive Disorders 2008, 26(4), 330-338.
- Tasker A, Ballard CG, Joachim C, Warden DR, Okello EJ, Perry RH, Khan N, Smith AD, Lehmann DJ, Perry EK. Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients. Neuroscience Letters 2008, 442(3), 297-299.
- Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, Milton I. Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dementia and Geriatric Cognitive Disorders 2008, 26(1), 32-42.
- O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. α4β2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(4), 356-361.
- Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiology of Disease 2007, 25(3), 561-570.
- Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. International Journal of Neuropsychopharmacology 2007, 10(2), 231-244.
- Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK. Selective loss of dopamine d2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 2007, 61(11), 903-911.
- Jaros E, Mahad D, Hudson G, Birchall D, Sawcer S, Griffiths P, Sunter J, Compston D, Perry R, Chinnery P. Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy. Neurology 2007, 69(2), 214-216.
- Ziabreva I, Ballard C, Johnson M, Larsen JP, McKeith I, Perry R, Aarsland D, Perry E. Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathology and Applied Neurobiology 2007, 33(5), 586-590.
- Margallo-Lana ML, Moore PB, Kay DWK, Perry RH, Reid BE, Berney TP, Tyrer SP. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: Incidence of cognitive decline, its relationship to age and neuropathology. Journal of Intellectual Disability Research 2007, 51(6), 463-477.
- Minger SL, Ekonomou A, Carta EM, Chinoy A, Perry RH, Ballard CG. Endogenous neurogenesis in the human brain following cerebral infarction. Regenerative Medicine 2007, 2(1), 69-74.
- Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2007, 67(11), 1931-1934.
- Walker Z, Jaros E, Walker RWH, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CLE. Dementia with Lewy bodies: A comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78(11), 1176-1181.
- Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the Developing and Senescent Human Brain. Annals of the New York Academy of Sciences 2006, 695(1), 69-72.
- Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathologica 2006, 111(2), 115-125.
- Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease 2006, 21(1), 50-56.
- Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, Longhi R, Riganti L, Gaimarri A, McKeith IG, Perry RH, Aarsland D, Larsen JP, Sher E, Beattie R, Clementi F, Court JA. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiology of Disease 2006, 23(2), 481-489.
- Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathology and Applied Neurobiology 2006, 32(2), 103-118.
- Momeni P, Cairns NJ, Perry RH, Bigio EH, Gearing M, Singleton AB, Hardy J. Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiology of Aging 2006, 27(5), 778.e1-778.e6.
- Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, Lightowlers RN, Turnbull DM. Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathology and Applied Neurobiology 2006, 32(4), 359-373.
- Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J, Wyper DJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. NeuroImage 2006, 33(2), 423-429.
- Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics 2006, 38(5), 515-517.
- Mackenzie IRA, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DMA. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathologica 2006, 112(5), 539-549.
- Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006, 67(11), 1931-1934.
- Polvikoski T, Kalaria RN, Perry R, Miller V, Kenny RA. Carotid sinus hypersensitivity associated with focal alpha-synucleinopathy of the autonomic nervous system. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(9), 1064-1066.
- Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C. Altered neurogenesis in Alzheimer's disease. Journal of Psychosomatic Research 2006, 61(3), 311-316.
- Thomas AJ, Hendriksen M, Piggott M, Ferrier IN, Perry E, Ince P, O'Brien JT. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathology and Applied Neurobiology 2006, 32(3), 296-303.
- Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. The K variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dementia and Geriatric Cognitive Disorders 2005, 19(5-6), 357-360.
- Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: A prospective, community-based study. Annals of Neurology 2005, 58(5), 773-776.
- Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK. Neuronal nicotinic acetylcholine receptor subunits in autism: An immunohistochemical investigation in the thalamus. Neurobiology of Disease 2005, 19(3), 366-377.
- Ballard CG, Perry RH, McKeith IG, Perry EK. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(9), 872-875.
- Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. Journal of Clinical Psychiatry 2005, 66(5), 633-637.
- Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behavioural Brain Research 2005, 161(2), 299-305.
- Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Annals of Neurology 2005, 57(4), 564-567.
- McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Bon Consortium DL. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.[see comment][erratum appears in Neurology. 2005 Dec 27;65(12):1992][summary for patients in Neurology. 2005 Dec 27;65(12):E26-7; PMID: 16380603]. Neurology 2005, 65(12), 1863-1872.
- Bohr IJ, Ray MA, McIntosh JM, Chalon S, Guilloteau D, McKeith IG, Perry RH, Clementi F, Perry EK, Court JA, Piggott MA. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [I-125]alpha-conotoxinMII in the striatum and thalamus. Experimental Neurology 2005, 191(2), 292-300.
- Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P, Moore P, Bryden L, Myers A, Doil LM, Tacey KM, Gibson AM, McKeith IG, Perry RH, Morris CM, Thal L, Morris JC, O'Donovan MC, Lovestone S, Grupe A, Hardy J, Owen MJ, Williams J, Goate A. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 2005, 136(1), 62-68.
- Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C. Absence of cholinergic deficits in "pure" vascular dementia. Neurology 2005, 64(1), 132-133.
- Religa D, Johnson M, Keverne J, Kalaria R, Jaros E, McKeith I, Perry R, Perry E, Naslund J. [meeting abstract] Decreased levels of amyloid-beta peptide in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. International Psychogeriatrics 2005, 17(s2), 314.
- Aarsland D, Andersen K, Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sorensen P. The rate of cognitive decline in Parkinson disease. Archives of Neurology 2004, 61(12), 1906-1911.
- Cairns NJ, Jaros E, Perry RH, Armstrong RA. Temporal lobe pathology of human patients with neurofilament inclusion disease. Neuroscience Letters 2004, 354(3), 245-247.
- Walker Z, Costa DC, Walker RWH, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CLE. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison. Neurology 2004, 62(9), 1568-1572.
- Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, Ravina B, Eerola J, Perry RH, Jaros E, Tienari P, Weiser R, Gwinn-Hardy K, Morris CM, Hardy J, Singleton AB. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004, 63(3), 554-556.
- Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. Journal of the Neurological Sciences 2004, 225(1-2), 39-49.
- Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D. Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380. Neuropsychopharmacology 2004, 29(1), 108-116.
- Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG. Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies. American Journal of Psychiatry 2004, 161(5), 843-849.
- Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK. Molecular analysis of nicotinic receptor expression in autism. Molecular Brain Research 2004, 123(1-2), 81-90.
- Cairns NJ, Jaros E, Perry RH, Amstrong RA. Laminar distribution of neurofilament inclusions and swollen achromatic neurons in neurofilament inclusion disease (NID). Neuroscience Research Communications 2004, 34(2), 104-111.
- Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, Piggott M. Involvement of alpha 6/alpha 3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [I-125]-alpha-conotoxin MII binding in the thalamus and striatum. Neuroscience Letters 2004, 372(3), 220-225.
- McKeith IG, Wesnes KA, Perry E, Ferrara R. Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders 2004, 18(1), 94-100.
- Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E. Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathology and Applied Neurobiology 2004, 30(6), 615-623.
- Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, Slade JY, Golkhar A, Matthews FE, Barber R, Kalaria RN, Ince PG. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathology and Applied Neurobiology 2004, 30(4), 385-395.
- Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VMY, Trojanowski JQ. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004, 63(8), 1376-1384.
- Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VMY, Trojanowski JQ. alpha-Internexin Is Present in the Pathological Inclusions of Neuronal Intermediate Filament Inclusion Disease. American Journal of Pathology 2004, 164(6), 2153-2161.
- Cairns NJ, Uryu K, Bigio EH, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee VMY, Trojanowski JQ. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathologica 2004, 108(3), 213-223.
- Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neuroscience Letters 2003, 341(3), 177-180.
- Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O'Brien JT. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. International Journal of Geriatric Psychiatry 2003, 18(1), 7-13.
- Piggott MA, Owens J, O'Brien J, Colloby S, Fenwick J, Wyper D, Jaros E, Johnson M, Perry RH, Perry EK. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. Journal of Chemical Neuroanatomy 2003, 25(3), 161-173.
- Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Annals of Neurology 2003, 54(2), 235-238.
- Graham AJ, Ray MA, Perry EK, Jaros E, Perry RH, Volsen SG, Bose S, Evans N, Lindstrom J, Court JA. Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. Journal of Chemical Neuroanatomy 2003, 25(2), 97-113.
- McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry 2003, 8(1), 46-57.
- Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E. Alzheimer's disease is associated with a selective increase in alpha 7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia 2003, 41(2), 207-211.
- Thomas AJ, O'Brien JT, Barber R, McMeekin W, Perry R. A neuropathological study of periventricular white matter hyperintensities in major depression. Journal of Affective Disorders 2003, 76(1-3), 49-54.
- Thomas A, Kalaria R, Perry R, O'Brien JT. [abstract] Neuropathological changes in late life depression. International Psychogeriatrics 2003, 15(s2), 159.
- Aarsland D, Ballard C, Larsen JP, McKeith I, O'Brien J, Perry R. [abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease. Nordic Journal of Psychiatry 2003, 57(2), 94.
- Burns, A.S.Y.W., Jaros, E., Cole, M., Perry, R., Pearson, A.D.J., Lunec, J. The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system. British Journal of Cancer 2002, 86(7), 1117-1123.
- Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, Gotti C, Cookson MR, Perry RH, Jaros E, Perry EK, Court JA. Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression. Neuroscience Letters 2002, 335(2), 134-138.
- Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002, 125(7), 1483-1495.
- Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, Perry RH. Ischemic basis for deep white matter hyperintensities in major depression - A neuropathological study. Archives of General Psychiatry 2002, 59(9), 785-792.
- Graham A, Court JA, Martin-Ruiz CM, Jaros E, Perry R, Volsen SG, Bose S, Evans N, Ince P, Kuryatov A, Lindstrom J, Gotti C, Perry EK. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience 2002, 113(3), 493-507.
- Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT. Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. Journal of Neurology, Neurosurgery and Psychiatry 2002, 73(5), 556-560.
- Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison D. Genetic abnormalities detected in genomic hybridisation epenclymomas by comparative. British Journal of Cancer 2002, 86(6), 929-939.
- Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison D. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. British Journal of Cancer 2002, 86(6), 929-939.
- Ballard CG, Court JA, Piggott M, Johnson M, O'Brien J, McKeith I, Holmes C, Lantos P, Jaros E, Perry R, Perry E. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Consciousness and Cognition 2002, 11(3), 461-474.
- Piggott M, Owens J, O'Brien J, Paling S, Wyper D, Fenwick J, Johnson M, Perry R, Perry E. Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain. Journal of Chemical Neuroanatomy 2002, 24(3), 211-223.
- SantaCruz KS, Walker Z, Swagerty D, Piggott MA, Ryo-Yang M, McKeith IG, Raghavan R, Jaros E, Perry RH. Clinical presentations in monozygotic twins with dementia with Lewy bodies. Journal of the American Medical Directors Association 2002, 3(3), 175-179.
- Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, Morris CM. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2002, 14(3-4), 167-175.
- Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. Journal of Affective Disorders 2002, 69(1-3), 219-223.
- Cairns NJ, Perry R, Jaros E, Lowe J, Skellerud K, Duckaerts C, Cruz-Sanchez F, Lantos P. A new dementia: Neurofilament inclusion body dementia. Journal of Neuropathology and Experimental Neurology 2002, 61(5), 451 abstract no. 35.
- Court JA, Ballard CG, Piggott MA, Johnson M, O'Brien JT, Holmes C, Cairns N, Lantos P, Perry RH, Jaros E, Perry EK. Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies. Pharmacology Biochemistry and Behavior 2001, 70(4), 571-579.
- Gilbertson, R., Hernan, R., Pietsch, T., Pinto, L., Scotting, P., Allibone, R., Ellison, D., Perry, R., Pearson, A.D.J., Lunec, J. Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma. Genes, Chromosomes and Cancer 2001, 31(3), 288-294.
- Gilbertson RJ, Hernan R, Lewin J, Pietsch T, Pinto L, Scotting P, Allibone R, Ellison D, Perry RH, Pearson ADJ, Lunec J. Novel ErbB4 juxtamembrane splice variants and the truncated ErbB2 receptor isoform are frequently expressed in childhood medulloblastoma. Genes, Chromosomes & Cancer 2001, 31(3), 288-294.
- Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: Implications for brain protection. Ageing Vulnerability: Causes and Interventions: Novartis Foundation Symposium 235 2001, 235, 49-65.
- Kalaria RN, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Ageing Vulnerability: Causes and Interventions: Novartis Foundation Symposium 235 2001, 235, 49-65.
- Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, Perry E, Nordberg A. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. Journal of Chemical Neuroanatomy 2001, 22(1-2), 115-126.
- Lloyd AJ, Grace JB, Jaros E, Perry RH, Fairbairn AF, Swann AG, O'Brien JT, McKeith IG. Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases. International Journal of Geriatric Psychiatry 2001, 16(3), 281-287.
- Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences 2001, 13(3), 374-379.
- O'Brien J, Thomas A, Ballard C, Brown A, Ferrier N, Jaros E, Perry R. Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biological Psychiatry 2001, 49(2), 130-136.
- Gilbertson, R., Wickramasinghe, C., Hernan, R., Balaji, V., Hunt, D., Jones-Wallace, D., Crolla, J., Perry, R., Lunec, J., Pearson, A.D.J., Ellison, D. Clinical and molecular stratification of disease risk in medulloblastoma. British Journal of Cancer 2001, 85(5), 705-712.
- Perry EK, Lee MLW, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. American Journal of Psychiatry 2001, 158(7), 1058-1066.
- Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O'Brien JT. A neuropathological study of vascular factors in late-life depression. Journal of Neurology Neurosurgery and Psychiatry 2001, 70(1), 83-87.
- O'Brien JT, Perry RH, Barber R, Gholkar AR, Thomas AJ. The association between white matter lesions on magnetic resonance imaging and non-cognitive symptoms. Annals of New York Academy of Sciences 2000, 903, 482-489.
- Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM. Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain 2000, 123(12), 2467-2474.
- Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I. One year follow-up of parkinsonism in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2000, 11(4), 219-222.
- Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E. Nicotinic receptors in dementia of Alzheimer, lewy body and vascular types. Acta Neurologica Scandinavica, Supplement 2000, 102(176), 34-41.
- Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nasland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, Jaros E, Perry R, Ballard C, McKeith I, Court J. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. European Journal of Pharmacology 2000, 393(1-3), 215-222.
- Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000, 98(1), 79-87.
- Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R. Neuropathological substrates of dementia and depression in vascular dementia. with a particular focus on cases with small infarct volumes. Dementia and Geriatric Cognitive Disorders 2000, 11(2), 59-65.
- Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000, 55(2), 302-304.
- Thomas AJ, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, Perry RH, O'Brien JT. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. American Journal of Psychiatry 2000, 157(10), 1682-1684.
- Pinto, L.I.B., Pearson, A.D.J., Perry, R., Lunec, J. Detection of amplified and transcribed sequences at the chromosome 12q13-15 locus in NGP neuroblastoma cells by Alu-PCR. British Journal of Cancer 2000, 83(Supplement 1), 36-36.
- Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Annals of Neurology 2000, 48(6), 868-876.
- Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: Prevalence and associations. Journal of Affective Disorders 2000, 59(2), 97-106.
- Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK. α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. Journal of Neurochemistry 1999, 73(4), 1635-1640.
- Barber R, Scheltens F, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery and Psychiatry 1999, 67(1), 66-72.
- Neill D, Curran MD, Middleton D, Mawhinney H, Edwardson JA, Mckeith I, Ballard C, Morris C, Ince P, Jaros E, Perry R. Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. Neuroscience Letters 1999, 275(2), 137-140.
- Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease. American Journal of Psychiatry 1999, 156(7), 1039-1045.
- Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry 1999, 73(4), 1590-1597.
- Middleton D, Mawhinney H, Curran MD, Edwardson JA, Perry R, McKeith I, Morris C, Ince PG, Neill D. Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease. Neuroscience Letters 1999, 262(2), 140-142.
- Briel RCG, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF. EEG findings in dementia with Lewy bodies and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1999, 66(3), 401-403.
- Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK. Dopaminergic activities in the human striatum: Rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 1999, 90(2), 433-445.
- Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. Pharmacogenetics and Genomics 1999, 9(1), 31-36.
- Singleton AB, Gibson AM, McKeith IG, Ballard CA, Perry RH, Ince PG, Edwardson JA, Morris CM. alpha(2)-Macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroreport 1999, 10(7), 1507-1510.
- McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH. What are the relations between Lewy body disease and AD?. Journal of Neural Transmission Supplement 1998, (54), 107-116.
- Lyras L, Perry RH, Perry EK, Ince PG, Jenner A, Jenner P, Halliwell B. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. Journal of Neurochemistry 1998, 71(1), 302-312.
- Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Human Molecular Genetics 1998, 7(5), 937-939.
- Piggott MA, Perry EK, Marshall EF, McKeith IG, Johnson M, Melrose HL, Court JA, Lloyd S, Fairbairn A, Brown A, Thompson P, Perry RH. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease. Biological Psychiatry 1998, 44(8), 765-774.
- El-Agnaf OMA, Curran MD, Wallace A, Middleton D, Murgatroyd C, Curtis A, Perry R, Jaros E. Mutation screening in exons 3 and 4 of α-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. NeuroReport 1998, 9(17), 3925-3927.
- Perry RH, McKeith IG, Perry EK. Lewy body dementia. Neuroscience News 1998, 1(3), 28-35.
- Gilbertson RJ, Clifford SC, MacMeekin W, Wright C, Perry RH, Kelly P, Pearson ADJ, Lunec J. Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma. Cancer Research 1998, 58(17), 3932-3941.
- Terzano S, Court JA, Fornasari D, Griffiths M, Spurden DP, Lloyd S, Perry RH, Perry EK, Clementi F. Expression of the alpha 3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Molecular Brain Research 1998, 63(1), 72-78.
- Burns ASYW, Jaros E, Pearson ADJ, Perry RH, Lunec J. Expression of p53, Waf-1, Bcl-2, and Bax in central primitive neuroectodermal tumours (cPNET). British Journal of Cancer 1998, 78(Suppl. 1), 64-64.
- Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM, Lamb H, Perry RH, Johnson M, Perry EK. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998, 87(1), 63-78.
- Ballard CG, McKeith I, Harrison R, O'Brien J, Adams R, Lowery K, Perry R, Ince P. Depression in dementia with Lewy bodies and Alzheimer's disease. Journal of Affective Disorders 1998, 27, 631-636.
- Perry E, Court J, Goodchild R, Griffiths M, Jaros E, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C, McKeith I, Perry R. Clinical neurochemistry: developments in dementia research based on brain bank material. Journal of Neural Transmission 1998, 105(8-9), 915-933.
- Perry EK, Ballard C, Spurden D, Cheng A, Johnson M, McKeith I, Piggott M, Perry R. Cholinergic systems in the human brain: psychopharmacology and psychosis. Alzheimers' Disease Review 1998, 3, 117-124.
- Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies - Distinctions between diseases. Neurology 1998, 50(2), 388-391.
- Ballard CG, O'Brien J, Lowery K, Ayre GA, Harrison R, Perry R, Ince P, Neill D, McKeith IG. A prospective study of dementia with Lewy bodies. Age and Ageing 1998, 27(5), 631-636.
- Ballard C, McKeith I, Burn D, Harrison R, OBrien J, Lowery K, Campbell M, Perry R, Ince P. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica 1997, 96(6), 366-371.
- Marshall EF, Perry RH, Perry EK, Piggott MA, Thompson P, Jaros E, Burn DJ. Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurologica Scandinavica 1997, 95(5), 287-292.
- Gilbertson, R., Perry, R., Kelly, P., Pearson, A.D.J., Lunec, J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Research 1997, 57(15), 3272-3280.
- Mann DMA, Iwatsubo T, PickeringBrown SM, Owen F, Saido TC, Perry RH. Preferential deposition of amyloid beta protein (A beta) in the form A beta(40) in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neuroscience Letters 1997, 221(2-3), 81-84.
- Rajan PB, Scott DJ, Perry RH, Griffith CDM. p53 protein expression in ductal carcinoma in situ (DCIS) of the breast. Breast Cancer Research and Treatment 1997, 42(3), 283-290.
- Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neuroscience Letters 1997, 234(1), 19-22.
- Singleton AB, Lamb H, Leake A, McKeith IG, Ince PG, Perry RH, Morris CM. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. NeuroReport 1997, 8(16), 3637-3639.
- Gilbertson R, Jaros E, Perry R, Kelly P, Lunec J, Pearson A. Mitotic percentage index: A new prognostic factor for childhood medulloblastoma. European Journal of Cancer Part A 1997, 33(4), 609-615.
- Curran M, Middleton D, Edwardson J, Perry R, McKeith I, Morris C, Neill D. HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. NeuroReport 1997, 8(6), 1467-1469.
- Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6), 479-484.
- Ballard C, Mckeith I, Harrison R, O'Brien J, Thompson P, Lowery K, Perry R, Ince P. Aspects of dementia. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. International Psychogeriatrics 1997, 9(4), 381-388.
- Morris AAM, Singh-Kler R, Perry RH, Griffiths PD, Burt AD, Wong CP, Gardner-Medwin D, Turnbull DM. Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. Journal of Child Neurology 1996, 11(5), 417-419.
- Bailey, S., Skinner, R., Lucraft, H. H., Perry, R. H., Todd, N., Pearson, A. D. J. Pineal tumours in the north of England 1968-93. Archives of Disease in Childhood 1996, 75(3), 181-185.
- Johnson M, Perry RH, Piggott MA, Court JA, Spurden D, Lloyd S, Ince PG, Perry EK. Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging. Neurobiology of Aging 1996, 17(4), 639-651.
- Piggott MA, Court JA, Perry EK, Lloyd S, Thomas NJ, Smith ZM, Johnson M, Perry RH, McKeith IG. Dopaminergic and nicotinic interactions in the human striatum in dementia with Lewy bodies, chronic schizophrenia and Parkinson's disease. European Neuropsychopharmacology 1996, 6(4), 103-104.
- Christie J, Lamb H, Singleton AB, Leake A, Melton LS, Perry RH, McKeith IG, Morris CM. Determination of the alpha-1 anti-chymotrypsin polymorphism in Alzheimer's disease. Alzheimer's Research 1996, 2, 201-204.
- McKenzie JE, Edwards RJ, Gentleman SM, Ince PG, Perry RH, Royston MC, Roberts GW. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathologica 1996, 91(5), 526-529.
- Court JA, Perry EK, Spurden D, Griffiths M, Kerwin JM, Morris CM, Johnson M, Oakley AE, Birdsall NJM, Clementi F, Perry RH. The role of the cholinergic system in the development of the human cerebellum. Developmental Brain Research 1995, 90(1-2), 159-167.
- Court JA, Perry EK, Spurden D, Griffiths M, Kerwin JM, Morris CM, Johnson M, Oakley AE, Birdsall N, Clementi Fig, Perry RH. The role of the cholinergic system in the development of the human cerebellum. Developmental Brain Research 1995, 90, 159-167.
- Raghavan R, Day KA, Perry RH. Rapid cycling bipolar affective disorder and familial learning disability associated with temporal lobe (occipitotemporal gyrus) cortical dysplasia. Journal of Intellectual Disability Research 1995, 39(6), 509-519.
- Gilbertson RJ, Pearson ADJ, Perry RH, Jaros EAB, Kelly PJ. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. British Journal of Cancer 1995, 71(3), 473-477.
- Davis M, Mendelow AD, Perry RH, Chambers IR, James OFW. Experimental Stroke and Neuroprotection in the Aging Rat Brain. Stroke 1995, 26(6), 1072-1078.
- Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM. Effects of Apolipoprotein E Genotype on Cortical Neuropathology in Senile Dementia of the Lewy Body Type and Alzheimer's Disease. Neurodegeneration 1995, 4, 443-448.
- Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration 1995, 4(4), 443-448.
- Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Journal of the Neurological Sciences 1995, 131(1), 65-70.
- Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 1995, 64(2), 385-395.
- Perry EK, Perry RH. Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness. Brain and Cognition 1995, 28(3), 240-258.
- Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: Evidence that the disorders are distinct. Alzheimer Disease & Associated Disorders 1995, 9(4), 218-222.
- McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). British Journal of Psychiatry 1994, 165, 324-332.
- McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Behavioural Neurology 1994, 7 (1), 21.
- Piggott MA, Perry EK, McKeith IG, Marshall E, Johnson M, Brown A, Court JA, Perry RH. Striatal dopaminergic Markers in Lewy body dementia with neuroleptic sensitivity and Parkinson's disease. Brain Research Association Abstr 1994, 11, 48.
- Piggott MA, Perry EK, McKeith IG, Marshall E, Perry RH. Striatal dopaminergic Markers in Lewy body dementia in relation to neuroleptic drug reaction. Behavioural Neurology 1994, 7, 27.
- Harrington CR, Perry RH, Perry EK, Hurt J, McKeith JG, Roth M, Wischik CM. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tan protein. Dementia 1994, 5(5), 215-228.
- Rempher R, Crook R, Houlden H, Duff K, Hutton M, Roberts GW, Raghavan R, Perry R, Hardy J. Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene. Lancet 1994, 344, 815-815.
- Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG, Perry RH. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 1994, 5(7), 747-749.
- Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. American Journal of Pathology 1994, 145(6), 1472-1484.
- Raghavan R, Khinnu C, Brown AG, Day KA, Tyrer SP, Ince PG, Perry EK, Perry RH. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (Trisomy 21). NeuroReport 1994, 5(11), 1393-1396.
- Marshall EF, Perry EK, Perry RH, McKeith IG, Fairbairn AF, Thompson P. Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders. Neuroscience Research Communications 1994, 14(1), 17-25.
- McKeith IG, Fairbairn AF, Perry RH, Briel R, Harrison R. Clinical features of Lewy body dementia. Behavioural Neurology 1994, 7 (1), 21.
- Penman-Splitt M, Wright C, Burn J, Perry R. Autosomal dominant transmission of Pallister-Hall Syndrome. Clinical Dysmorphism 1994, 3, 301-308.
- St-Clair D, Norman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and aged-matched controls. Neuroscience Letters 1994, 176, 45-46.
- Royston MC, Mann D, Pickering-Brown S, Owens F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R, Hardy J, Roberts GW. Apolipoprotein E ε2 Allele promotes longevity and protects patients with Down's syndrome from dementia. NeuroReport 1994, 5, 2583-2585.
- Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994, 343(8912), 1565-1565.
- McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH. An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994, 44(5), 872-877.
- Griffiths PD, Perry RH, Crossman AR. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease. Neuroscience Letters 1994, 169(1-2), 68-72.
- Leake A, Moore PB, Leitch M, Ayre K, Perry RH, Ince PG, Ferrier IN. The serotonergic system Alzheimer's disease and normal neocortical post-mortem brain: neurochemical and clinical correlates. Neurology, Psychiatry Brain Research 1993, 2, 53-59.
- Court JA, Perry EK, Johnson M, Piggott MA, Kerwin JA, Perry RH, Ince PG. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Developmental Brain Research 1993, 74(1), 73-82.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. p53 mutation and over-expression are indicators of poor prognosis in primitive neuroectodermal tumours. British Journal of Cancer 1993, 67, Supplement XX, 20.
- Piggott MA, Perry EK, Perry RH, Scott D. N-methyl-D-aspartate (NMDA) and non-NMDA binding sites in developing human frontal cortex. Neuroscience Research Communications 1993, 12(1), 9-16.
- Perry EK, Perry RH. Neurochemical pathology and therapeutic strategies in degenerative dementia. International Review of Psychiatry 1993, 5, 363-380.
- Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, Ferrier IN, Irving D, Perry RH. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1993, 6(3), 167-177.
- Raghaven R, Irving D, Brown A, Ince IG, Perry RH. Lewy Body Prevalence in Parkinson's Disease, Senile Dementia of Lewy body Type, and the normal elderly. Neuropathoology and Applied Neurobiology 1993, 123.
- Kerwin JM, Morris CM, Johnson M, Perry RH, Perry EK. Hippocampal p75 Nerve Growth Factor Receptor Immunoreactivity in Development, Normal Aging and Senescence. Acta Anatomica 1993, 147(4), 216-222.
- Raghaven R, Ince PG, Perry RH. Discordant Phenotypic expression for Alzheimer's disease in middle-aged cases of Trisomy 21 (Down's syndrome). Neuropathology and Applied Neurobiology 1993, 123.
- Raghavan R, Khinnu C, Brown A, Irving D, Ince PG, Day K, Tyrer SP, Perry RH. Detection of Lewy bodies in Trisomy 21 (Downs syndrome). Canadian Journal of Neurological Sciences 1993, 20(1), 48-51.
- Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, Perry RH. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease. Alzheimer Disease & Associated Disorders 1993, 7(2), 69-79.
- Johnson M, Perry EK, Ince PG, Shaw PJ, Perry RH. Autoradiographic comparison of the distribution of [3H]MK801 and [3H]CNQX in the human cerebellum during development and aging. Brain Research 1993, 615(2), 259-266.
- Perry EK, Court JA, Johnson M, Smith CJ, James V, Cheng AV, Kerwin JM, Morris CM, Piggott MA, Edwardson JA, Birdsall NJM, Turner JT, Perry RH. Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus. Hippocampus 1993, 3(3), 307-315.
- Jaros, E., Lunec, J., Perry, R.H., Kelly, P.J., Pearson, A.D.J. P53 Protein Overexpression Identifies a Group of Central Primitive Neuroectodermal Tumors with Poor Prognosis. British Journal of Cancer 1993, 68(4), 801-807.
- Stuart AG, Pearson ADJ, Emslie J, Lennard AL, Davison EV, Perry RH, Crawford PJ. Cytogenetic abnormalities in a disseminated medulloblastoma. Medical and Pediatric Oncology 1993, 21(4), 295-298.
- Gentleman SM, Williams B, Royston MC, Jagoe R, Clinton J, Perry RH, Ince PG, Allsop D, Polak JM, Roberts GW. Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neuroscience Letters 1992, 142(1), 9-12.
- Jabeen S, McKeith IG, Fairbairn AF, Perry RH, Ferrier IN. Psychotic Symptoms in Alzheimer’s Disease. International Journal of Geriatric Psychiatry 1992, 7(5), 341-345.
- Gilbertson RJ, Pearson ADJ, Jaros EB, Perry RH. Prognostic Significance of Mitotic Index and c-erbB2 Oncogene Product in Childhood Medulloblastoma. British Journal of Cancer 1992, 65, 974.
- Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson ADJ. Prognostic implications of p53 protein, Epidermal growth factor receptor, and Ki-67 labelling in brain tumours. British Journal of Cancer 1992, 66, 373-385.
- Jaros EAB, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson ADJ. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. British Journal of Cancer 1992, 66(2), 373-385.
- McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine 1992, 22(4), 911-922.
- McKeith I, Fairbairn A, Perry RH, Thompson P, Perry EK. Neuroleptic Sensitivity in Patients with Senile Dementia of Lewy Body Type. BMJ 1992, 305(6855), 673-678.
- Kerwin JM, Morris CM, Perry RH, Perry EK. Nerve Growth Factor Receptor-Like Immunoreactivity in the Human Spinal Cord. Acta Anatomica 1992, 144(4), 348-353.
- Raghavan R, Khin-Nu C, Brown A, Perry RH. Lewy bodies in Down's syndrome. Journal of Neuropathology and Applied Neurobiology 1992, 18, 639.
- Dedman DJ, Treffry A, Candy JM, Taylor GAA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochemical Journal 1992, 287, 509-514.
- Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neuroscience Letters 1992, 143(1-2), 101-104.
- Johnson M, Perry EK, Shaw PJ, Ince PG, Perry RH. Glutamate receptor autoradiography in human development and ageing: CNQX and MK-801 in the cerebellum. Journal of Neuropathologhy and Applied Neurobiology 1992, 18, 639.
- Piggott MA, Perry EK, Sahgal A, Perry RH. Examination of Parameters Influencing [3H]MK-801 Binding in Postmortem Human Cortex. Journal of Neurochemistry 1992, 58(3), 1001-1008.
- Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiology of Aging 1992, 13(3), 393-400.
- Johnson M, Perry EK, Ince PG, Shaw PJ, Perry RH. Comparison of the distribution of (3H)-MK801 and (3H)‑CNQX binding in the developing and aging human cerebellum. Brain Research 1992, 615, 259-266.
- McKeith IG, Fairbairn AF, Perry RH. Clinical Diagnostic-Criteria for Lewy Body Dementia. Dementia 1992, 3(4), 251-252.
- Perry EK, Court JA, Johnson M, Piggott MA, Perry RH. Autoradiographic distribution of [3H]nicotine binding in human cortex: Relative abundance in subicular complex. Journal of Chemical Neuroanatomy 1992, 5(5), 399-405.
- Court JA, Piggott MA, Perry EK, Barlow RB, Perry RH. Age-associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity. Neuroscience Research Communications 1992, 10(3), 125-133.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. ADJ Prognostic significance of p53 protein expression/p53 gene mutation in childhood and adult primitive neuroectodermal tumours. Journal of Neuroathology and Applied Neurobiology 1992, 18, 628.
- Piggott MA, Perry EK, Perry RH, Court JA. [3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging. Brain Research 1992, 588(2), 277-286.
- Hatfield RH, Mendelow AD, Perry RH, Alvarez LM, Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathology and Applied Neurobiology 1991, 17(1), 61-67.
- Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D, Perry RH. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences 1991, 640, 197-202.
- Ferrier IN, Leake A, Cheng AV, McKeith IG, Perry RH. Serotonergic Mechanisms in Affective Disorders. Biological Psychiatry 1991, 29, 215S.
- Perry E, Court J, Whiting P, Edwardson J, Hughes D, Barlow R, Perry R. Role of the Nicotinic Receptor in Dementia. Biological Psychiatry 1991, 2, 820-824.
- Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. Journal of the Neurological Sciences 1991, 106(2), 142-152.
- Jaros E, Perry RH, Pearson ADJ, Crawford PJ, Mendelow ADM, Sengupta RP. p53 Expression in CNS Tumours. British Journal of Neurosurgery 1991, 5, 211.
- Gilbertson R, Pearson ADJ, Jaros EB, Perry RH. Oncogene Product and DNA Ploidy in Childhood Medulloblastoma. Unioted Kingdom Children's Cancer Study Group 1991, 123-1234.
- Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain 1991, 114(3), 1363-1379.
- Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biological Psychiatry 1991, 29(4), 357-364.
- Jaros E, Pearson ADJ, Perry RH. Immunohistochemistry of p53 protein, Epidermal Growth Factor Receptor (EGFR) and Ki -67 Labelling in Brain Tumours. Neuropathology and Applied Neurobiology 1991, 17, 522-523.
- Kerwin J, Morris C, Oakley A, Perry R, Perry E. Distribution of Nerve Growth Factor Receptor Immunoreactivity in the human hippocampus. Neuroscience Letters 1991, 121, 178-182.
- Smith PEM, Irving D, Perry RH. Density, Distribution and Prevalence of Lewy Bodies in the Elderly - Influence of Neuropsychiatric Bias with Epidemiologic and Diagnostic Implication. Neuroscience Research Communications 1991, 8(2), 127-135.
- Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1991, 106(1), 50-55.
- Gentleman S, Perry RH, Roberts GW. Correlation between ß-amyloid Protein (ßAP) Load and Test Scores in AD. Journal of Neuropathology and Applied Neurobiology 1991, 17, 530.
- Edwardson JA, Perry RH, McKeith IG, Marshall E, Perry EK. Clinical, Pathological and Neurochemical aspects of Lewy body Dementia. British Association of Psychopharmacology 1991, ?, 2.
- Piggott MA, Candy JM, Perry RH. [3H]Nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases. Brain Research 1991, 565(1), 42-47.
- Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF. Visual Hallucinations as a Presenting Symptom of Dementia ‑ a type of Lewy body disease?. Journal of Geriatric Psychiatry 1990, 5, 276-277.
- Perry EK, Perry RH, Kerwin JM, Blessed G. Visual hallucinations and the cholinergic system in dementia. Journal of Neuurology, Neurosurgery and Psychiatry 1990, 53, 1-11.
- Wariyar UK, Welch RJ, Milligan DWA, Perry RH. Sonographic and pathological features of callosal hypoplasia in non-ketotic hyperglycinaemia. Archives of Disease in Childhood 1990, 65(7), 670-671.
- Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences 1990, 95(2), 119-139.
- Smith PEN, Irving D, Ince PG, Perry RH. Prevalence of Lewy body Formation in the Aging Population. Journal of Neuropathology and Applied Neurobiology 1990, 542-543.
- Smith PEN, Perry RH, Fairbairn AF. Parkinson's disease and dementia associated with Lewy and Pick bodies. Journal of Neuropathology and Applied Neurobiology 1990, 123-1234.
- Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. Journal of the Neurological Sciences 1990, 99(2-3), 185-197.
- Court JA, Perry EK, Perry RH. Nicotine inhibits the release of H3 GABA from rat and human cerebral cortex, in vitro. Neuroscience Research Communications 1990, 7(1), 9-15.
- Kerwin JM, Perry EK, Morris CM, Perry RH. Nerve Growth Factor Receptor‑Positive Fibre Pathways in the Human Neocortex. Biochemical society Transactions 1990, 18, 661-663.
- Leake A, Perry EK, Perry RH, Jabeen S, McKeith IG, Ferrier IN. Neocortical Concentrations of Corticotrophin‑Releasing Hormone, Somatostatin and Vasopressin in Senile Dementia of the Alzheimer and Lewy Body types ‑ Comparison with Parkinson's disease and Correlations with Disease Severity. Biological Psychiatry 1990, 29, 357-364.
- White MC, Daniels M, Newland P, Thompson CJ, Cook D, Dewar J, Perry R, Jewitt R, Mathias D, Murdoch AP, Kendall-Taylor P. LH and FSH secretion and responses to GnRH and TRH in patients with clincally functionless pituitary adenomas. Clinical Endocrinology 1990, 32(6), 681-688.
- Perry RH, Irving D, Tomlinson BE. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. Journal of the Neurological Sciences 1990, 100(1-2), 223-233.
- Narang HK, Perry RH. High Incidence of Creutzfeldt‑Jakob Disease in Northern England. Journal of Neuropathology and Applied Neurobiology 1990, 16, 259-259.
- Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathology and Applied Neurobiology 1990, 16(6), 477-488.
- Smith PEN, Irving D, Perry RH. Distribution and Density of Cortical Lewy bodies in Parkinson's disease: Relationship to Age and Dementia. Journal of Neuropathology and Applied Neurobiology 1990, 538-539.
- Perry RH, Irving D, Blessed G, Perry EK, Smith CJ, Fairbairn AF. Dementia in Old Age: Identification of a Clinically and Pathologically Distinct Disease Category. Advances in Neurology 1990, 51, 41-46.
- Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biological Psychiatry 1990, 28(7), 603-608.
- Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and Subcortical Pathology in Parkinson's disease: Relationship to Parkinsonian Dementia. Advances in Neurology 1990, 53, 35-40.
- Perry EK, Smith CJ, Court JA, Perry RH. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. Journal of Neural Transmission – Parkinson’s Disease and Dementia Section 1990, 2(3), 149-158.
- Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF. Cholinergic and Dopaminergic Activities in Senile Dementia of Lewy body type. Alzheimer's Disease and Associated Disorders 1990, 4 (2), 87-95.
- Griffiths PD, Sambrook MA, Perry R, Crossman AR. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease. Journal of the Neurological Sciences 1990, 100(1-2), 131-136.
- Perry EK, Kerwin JM, Perry RH, Irving D, Blessed G, Fairbairn AF. Cerebral Cholinergic Activity is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy body Type. Dementia 1990, 1, 2-4.
- Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R, Swaab DF, Whetsell WO, Zemlan FP. Biochemical Assay of Alzheimer's Disease - Associated Protein(s) in Human Brain Tissue: A Clinical Study. JAMA - Journal of the American Medical Association 1990, 263(21), 2907-2910.
- Ferrier IN, Cheng AV, Jabeen S, McKeith IG, Perry RH, Perry EK. 5HT receptor subtypes in dementing disorders. Journal of Psychopharmacology 1990, 4 (4), 268-268.
- Xuereb JH, Perry RH, Perry EK, Candy JM, Marshall E, Bonham JR. The Thalamus in Parkinson's disease and Alzheimer's Disease: Morphologic and Neurochemical Changes. Neuropathology and Applied Neurobiology 1989, 15, 274-274.
- Charlton FG, Candy JM, Perry EK, Perry RH. The Status of Excitatory Dicarboxylic Amino Acid Uptake Sites in the Cerebral Cortex in Alzheimer's and Parkinson's Diseases. British Journal of Pharmacology 1989, 96, 350-350.
- Perry RH, Ferrier IN. The relationship of serotonin to depression in Parkinson's disease. Transmission 1989, 9, 11-11.
- Perry EK, Smith CJ, Perry RH, Whitford C, Johnson M, Birdsall NJ. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. Journal of Chemical Neuroanatomy 1989, 2(4), 189-199.
- Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of Cholinergic Transmission in the Human Thalamus with special reference to Parkinson's disease and Alzheimer's Disease. Journal of Neuropathology and Applied Neurobiology 1989, 15, 596-596.
- Perry EK, Smith CJ, Perry RH, Johnson M, Fairbairn AF. Nicotinic (3H nicotine) receptor binding in human brain: characterization and involvement in cholinergic neuropathology. Neuroscience Research Communications 1989, 5(2), 117-124.
- Bowen N, Pearson ADJ, Davison EV, Gardner-Medwin D, Crawford PJ, Perry RH. Multiple Chromosomal Rearrangements in a Childhood Ependymoma. Cancer, genet and Cuytogen 1989, 36, 25-30.
- Ince PG, Irving D, Perry RH. Differential Distribution of Alzheimer‑type Pathology in Senile Dementia of Lewy Body type: Comparison with Alzheimer's Disease. Journal of Neuropathology and Applied Neurobiology 1989, 15, 599-599.
- Mantle D, Lauffart B, Perry EK, Perry RH. Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease. Journal of the Neurological Sciences 1989, 89(2-3), 227-234.
- Perry EK, Perry RH. Amyloid and Alzheimer's Disease: a Question of Specificity. Neurobiology or Aging 1989, 10, 473-474.
- Purohit DP, Perry RH. Quantitative analysis of Alzheimer‑type Pathology in the Hippocampus in Alzheimer's disease. Neuroscience Abstracts 1988, 123-1234.
- Ferrier IN, Perry RH, Fairbairn AF, McKeith IG, Leake A, Yates M. Post-mortem investigation of neurochemical and neuro-peptidergic hypothesis of depression. Psychopharmacology 1988, 96(1 (suppl.)), 98-98.
- Irving D, Perry RH, Blessed G, Perry EK, Fairbairn AF. Neuropathological Observations on an Atypical Dementing Syndrome. Journal of Neuropathology Applied Neurobiology 1988, 511. In Preparation.
- Smith CJ, Perry EK, Perry RH, Candy JM, Johnson M, Bonham JR, Dick DJ, Fairbairn A, Blessed G, Birdsall NJM. Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders. Journal of Neurochemistry 1988, 50(3), 847-856.
- Bown NP, Pearson ADJ, Davison EV, Gardner-Medwin D, Crawford PJ, Perry RH. Multiple chromosome rearrangements in a childhood ependymoma. Cancer Genetics and Cytogenetics 1988, 36(1), 25-30.
- Perry RH, Irving D, Blessed G, Perry EK. Identification of an Atypical Dementia Syndrome. European Brain Research 1988, 123-1234.
- Perry RH, Oakley AE, Perry EK. Distribution of Brodmann areas in Coronal sections of the Human Brain. Journal of Neuropathology and Applied Neurobiology 1988, 6, 519-519.
- Whitford CA, Candy JM, Edwardson JA, Perry RH. Cortical Somatostatinergic System not affected in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1988, 86, 13-18.
- Cross AJ, Slater P, Perry EK, Perry RH. An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia. Neurochemistry International 1988, 13(1), 89-96.
- Perry EK, Perry RH. Ageing and Dementia: Neurochemical and Neuropathological Comparisons. Life Sciences Research Report 1988, 43, 123-1234.
- McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 5-HT Receptor Binding in Postmortem Brain from Patients with Affective Disorders. Biological Psychiatry in Clinical Practice 1988, 1 (3), 10-11.
- Perry EK, Perry RH. Unfolding the Nature of Senile Plaque Amyloid. Neurobiology of Aging 1987, 7, 437-437.
- Perry EK, Perry RH. Unfolding the Nature of Senile Plaque Amyloid. Neurobiology of Aging 1987, 7, 437-437.
- Morris CM, Court JA, Moshtaghie AA, Skillen A, Candy JM, Perry RH, Edwardson JA, Fairbairn AF. Transferrin and Transferrin Receptors in Normal Brain and in Alzheimer's Disease. Biochemical Society Transactions 1987, 15, 891-892.
- Cross AJ, Slater P, Simpson M, Royston C, Deakin JFW, Perry RH, Perry EK. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neuroscience Letters 1987, 79(1-2), 213-217.
- Court JA, Ferrier IN, Griffiths HW, Lauffart B, Perry RH, Candy JM, Fairbairn AF, Blessed G. Serum Creatine Kinase‑BB levels and Cerebral Cortical Creatine Kinase Activity in Senile Dementia of the Alzheimer Type. Journal of Neurological Sciences 1987, 80, 111-123.
- Court JA, McDermott JR, Gibson AM, Marshall E, Bloxham CA, Perry RH, Edwardson JA. Raised Thyrotrophin-Releasing Hormone, Pyroglutamylamino Peptidase, and Proline Endopeptidase Are Present in the Spinal Cord of Wobbler Mice but Not in Human Motor Neurone Disease. Journal of Neurochemistry 1987, 49(4), 1084-1090.
- Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(6), 806-809.
- Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular Forms of Butyrylcholinesterase in the Human Neocortex During Development and Degeneration of the Cortical Cholinergic System. Journal of Neurochemistry 1987, 48(6), 1687-1692.
- Atack JR, Perry EK, Bonham JR, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. Journal of Neurochemistry 1987, 48(6), 1845-1850.
- Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJM. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain - A preliminary study in Alzheimer's disease. Neuroscience Letters 1987, 82(2), 227-232.
- Charlton BG, Ferrier IN, Perry RH. Distribution of corticotropin-releasing factor-like immunoreactivity in human brain. Neuropeptides 1987, 10(4), 329-334.
- Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford C, Candy JM. Cortical Neuropathological and Neurochemical Substrates of Alzheimer's and Parkinson's Disease. Journal Neural Transmission 1987, 24, 131-136.
- McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. Journal of Affective Disorders 1987, 13(1), 67-74.
- Perry EK, Perry RH. Unfolding the nature of senile plaque amyloid. Neurobiology of Aging 1986, 7(6), 437-439.
- Smith CJ, Perry EK, Perry RH, Candy JM, Johnson M. The Status of Cholinergic Receptors in Human Cognitive Disorders. Biochemical Society Trans 1986, 14 (6), 1162-1163.
- Purohit DP, Dick DJ, Perry RH, Foster JF. Solitary Extranodal Lymphoma of Sciatic Nerve. Journal of Neuropathology Applied Neurobiology 1986, 123.
- Purohit DP, Dick DJ, Perry RH, Lyons PR, Schofield IS, Foster JB. Solitary extranodal lymphoma of sciatic nerve. Journal of the Neurological Sciences 1986, 74(1), 23-34.
- Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Experimental and Molecular Pathology 1986, 44(1), 111-116.
- Perry RH. Recent advances in neuropathology. British Medical Bulletin 1986, 42(1), 34-41.
- Ferrier IN, McKeith IG, Cross AJ, Perry EK, Candy JM, Perry RH. Post Mortem Neurochemical Studies in Depression. Annuals New York Acadamy of Science 1986, 487, 128-142.
- Perry EK, Perry RH, Smith CJ, Candy JM. Non Cholinergic Systems in Alzheimer's disease. European Society Neurochemistry 1986, 123 - 1234.
- Perry EK, Smith CJ, Atack JR, Candy JM, Johnson M, Perry RH. Neocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain. Journal of Neurochemistry 1986, 47(4), 1262-1269.
- Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System. Journal of Neurochemistry 1986, 47(1), 263-277.
- Candy JM, Fairbairn AF, Johnson M, Perry EK, Perry RH, Smith CJ. Hippocampal Cholinergic (muscarinic and putative nicotinic) Receptors in Human Cognitive Disorders. British Journal of Pharmacology 1986, 87, 359-359.
- Taylor GR, Carter GI, Crow TJ, Fairbairn AF, Perry EK, Perry RH. Factors Influencing the Preservation of RNA in Postmortem Brain Tissue. Journal of Neuropathology Applied Neurobiology 1986, 1234.
- Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A. Cholinergic receptors in cognitive disorders. Canadian Journal of Neurological Sciences 1986, 13(suppl. 4), 521-527.
- Edwardson JA, Klinowski J, Oakley AE, Perry RH, Candy JM. Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease. CIBA Foundation Symposium 1986, 121, 160-179.
- Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1986, 1(8477), 354-357.
- Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. Journal of the Neurological Sciences 1985, 71(2-3), 315-323.
- Purohit D, Perry RH, Tomlinson BE, Irving D. Pathophysiological Significance of Neurofibrillary Tangle Formation in Mid‑Brain and Brain Stem Nuclei in Alzheimer's Disease. Neuropathology and Applied Neurobiology 1985, 11, 499-500.
- Candy JM, Perry RH, Thompson JE, Johnson M, Oakley AE. Neuropeptide localization in the substantia innominata and adjacent regions of the human brain. Journal of Anatomy 1985, 140, 309-327.
- Candy JM, Perry EK, Perry RH, Bloxham CA, Thompson J, Johnson M, Oakley AE, Edwardson JA. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neuroscience Letters 1985, 61(1-2), 91-95.
- Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1985, 48(5), 413-421.
- Atack JR, Perry EK, Perry RH, Wilson ID, Bober MJ, Blessed G, Tomlinson BE. Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. Journal of the Neurological Sciences 1985, 70(1), 1-12.
- Candy JM, Perry RH, Yates M. Autoradiographic Localisation of 5‑HT and Imipramine Binding Sites in the Raphe Nuclei of the Human Brain. British Journal of Pharmacology 1985, 84, 90-90.
- Wester P, Bateman DE, Dodd PR, Edwardson JA, Hardy JA, Kidd AM, Perry RH, Singh GB. Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochemical Pathology 1985, 3(3), 169-180.
- Perry EK, Perry RH. A review of neuropathological and neurochemical correlates of Alzheimer's disease. Danish Medical Bulletin 1985, 32, 27-34.
- Perry RH, Candy JM, Perry EK, Thompson J, Oakley AE. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. Journal of Anatomy 1984, 138, 713-732.
- Bateman DE, Candy JM, Perry RH, Edwardson JA. The Autoradiography of Human Gliomas. Neuro-Oncology 1984, 2, 276-276.
- Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. Journal of the Neurological Sciences 1984, 64(2), 109-117.
- Candy JM, Oakley AE, Atack J, Perry RH, Perry EK, Edwardson JA. New observations on the nature of senile plaque cores. Developments in Neuroscience 1984, 17, 301-304.
- Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984, 23(12, part 2), 1561-1569.
- Perry EK, Candy JM, Perry RH. Neuropathology of the cholinergic system in the human brain. Developments in Neuroscience 1984, 17, 279-282.
- Candy JM, Perry EK, Perry RH, Biggins JA, Tomlinson BE. Neuropathological and Neurochemical Changes Associated with Alzheimer's Disease. Age and Aging 1984, 13, 182-182.
- Candy JM, Perry RH, Thompson JE. Lack of Muscarinic Binding Sites on Cholinergic Neurones in the Human Basal Forebrain. British Journal of Pharmacology 1984, 81, 62-62.
- Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbairn AF. Intralaminar Neurochemical Distributions in Human Midtemporal Cortex: Comparison Between Alzheimer's Disease and the Normal. Journal of Neurochemistry 1984, 42(5), 1402-1410.
- Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: Comparisons with Parkinson's disease. Neuroscience Letters 1984, 51(3), 353-357.
- Biggins JA, McDermott JR, Smith AI, Candy JM, Perry RH, Bateman DE, Edwardson JA. Chromatographic characterization of neuropeptides in post mortem human brain. Journal of the Neurological Sciences 1984, 66(1), 47-58.
- Candy JM, Court JA, Perry RH, Smith CJ. Carbachol‑stimulated Phosphatidylinositol Hydrolysis in the Cerebral Cortex after Freezing and Post Mortem Delay. Br J Pharmac 1984, 83, 356-356.
- Candy JM, Perry EK, Perry RH, Tomlinson BE. The Nucleus of Meynert in Senile Dementia of the Alzheimer type: Neuropathological and Neurochemical Observations. Neuropathol Appl Neurobiol 1983, 6, 334-335.
- Perry EK, Perry RH, Candy JM. The Cholinergic System and Human Memory Disorders: Some Enigmas and Variations. Journal of Neurochemistry 1983, 41, S34 - S34.
- Biggins JA, Perry EK, McDermott JR, Smith AI, Perry RH, Edwardson JA. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Journal of the Neurological Sciences 1983, 58(1), 117-122.
- Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1983, 59(2), 277-289.
- Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE. Monoamine metabolism in senile dementia of Alzheimer type. Journal of the Neurological Sciences 1983, 60(3), 383-392.
- Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form. Neuroscience Letters 1983, 40(2), 199-204.
- Hardy JA, Dodd PR, Oakley AE, Perry RH, Edwardson JA, Kidd AM. Metabolically Active Synaptosomes Can Be Prepared from Frozen Rat and Human Brain. Journal of Neurochemistry 1983, 40(3), 608-614.
- Pearson, A. D. J., Craft, A. W., Perry, R. H., Kalbag, R. M., Evans, R. G. B. Four primary tumors in one child. Cancer 1983, 52(12), 2363-2368.
- Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH. Decreased imipramine binding in the brains of patients with depressive illness. British Journal of Psychiatry 1983, 142, 188-192.
- Hardy JA, Dodd PR, Oakley AE, Kidd AM, Perry RH, Edwardson JA. Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release. Neuroscience Letters 1982, 33(3), 317-322.
- Hardy JA, Dodd PR, Kidd AM, Perry RH, Edwardson JA. Use of Human Brain to Study Amino‑Acid Neurotransmitters. Neuroscience 1982, 7, 590-590.
- Perry EK, Perry RH. The cholinergic system in Alzheimer's disease. Trends in Neurosciences 1982, 5(8), 261-262.
- Perry EK, Perry RH. Neurotransmitter and Neuropeptide Systems in Alzheimer-type Dementia. Exper Brain Res Suppl 1982, 5, 140-145.
- Perry EK, Perry RH, Tomlinson BE. Influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neuroscience Letters 1982, 29(3), 303-307.
- Tomlinson BE, Perry RH. Genetics of Alzheimer's Disease. British Medical Journal 1982, 285, 58-59.
- Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease. Neuroscience Letters 1982, 33(3), 311-315.
- Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. BMJ 1981, 282(6258), 93-94.
- Perry EK, Oakley AE, Candy JM, Perry RH. Properties and possible significance of substance P and insulin fibrils. Neuroscience Letters 1981, 25(3), 321-325.
- Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE. Neuropeptides in Alzheimer's disease, depression and schizophrenia : A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex. Journal of the Neurological Sciences 1981, 51(3), 465-472.
- Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. Journal of the Neurological Sciences 1981, 51(2), 279-287.
- Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A. NEUROCHEMICAL ACTIVITIES IN HUMAN TEMPORAL-LOBE RELATED TO AGING AND ALZHEIMER-TYPE CHANGES. Neurobiology of Aging 1981, 2(4), 251-256.
- Oakley AE, Perry RH, Candy JM, Perry EK. Electron microscopic appearances and implications of neuropeptide fibrillary forms. Neuropeptides 1981, 2(1), 1-11.
- Valladares JB, Perry RH, Kalbag RM. Malignant choroid plexus papilloma with extraneural metastasis - Case report. Journal of Neurosurgery 1980, 52(2), 251-255.
- Perry RH, Blessed G, Perry EK, Tomlinson BE. Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. Age and Ageing 1980, 9(1), 9-16.
- Sanders DJ, Zahedi-Asi S, Lund PK, Murr A, Perry EK, Perry RH. Gastrin;CCK Immunoreactivity in Human Cerebral Cortical Grey and White Matter. Int Union Physiol Sci 1980, 14, 679-679.
- Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH. Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase. Neuroscience Letters 1980, 18(1), 105-110.
- Tomlinson BE, Perry RH, Stewartwynne EG. Influence of site of origin of lung carcinomas on clinical presentation and central nervous system metastase. Journal of Neurology, Neurosurgery and Psychiatry 1979, 42(1), 82-88.
- Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 1978, 2(6150), 1457-1459.
- Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain Cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology 1978, 4(4), 273-277.
- Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia ☆: Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. Journal of the Neurological Sciences 1977, 34(2), 247-265.
- Perry EK, Perry RH, Tomlinson BE. Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex. Neuroscience Letters 1977, 4(3-4), 185-189.
- Perry EK, Perry RH. Cholinergic and gaba systems in dementia and normal old-age. British Journal of Psychiatry 1977, 131(3), 319-319.
- Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neuroscience Letters 1977, 6(1), 85-89.
- Ramani PS, Perry RH, Tomlinson BE. Role of ligamentum flavum in the symptomatology of prolapsed lumbar intervertebral discs. Journal of Neurology, Neurosurgery and Psychiatry 1975, 38(6), 550-557.
- Sengupta RP, So SC, Perry RH. Nodular fasciitis: An unusual cause of extradural spinal cord compression. British Journal of Surgery 1975, 62(7), 573-575.
- Perry RH, Ramani PS, McAllister V, Kalbag RM, Kanagasudaram CR. Nodular fasciitis causing unilateral proptosis. British Journal of Ophthalmology 1975, 59(8), 404-408.
-
Authored Book
- Perry RH, McKeith IG, Perry EK. Dementia with Lewy Bodies : Clinical, Pathological and Treatment Issues. Cambridge: Cambridge University Press, 1996.
-
Book Chapters
- Francis PT, Perry EK, Piggott MA, Duda JE. Neurochemical pathology of dementia with Lewy bodies. In: O'Brien, J; McKeith, I; Ames, D; Chiu, E, ed. Dementia with Lewy Bodies. Oxford: Taylor & Francis, 2006, pp.167-175.
- Perry EK, Burn DJ, McKeith IG, O'Brien J, Perry R. Lewy body diseases. In: Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott Williams & Wilkins, 2002, pp.1301-1316.
- Perry RH, Jaros EB, Irving D, Scoones DJ, Brown A, McMeakin WM, Perry EK, Morris CM, Kelly PJ, Ince PG. What is the neuropathological basis of dementia associated with Lewy bodies?. In: Dementia with Lewy Bodies: Clinical, Pathological, and Treatment Issues. Cambridge: Cambridge University Press, 1996, pp.212-224.
- Perry EK, Perry RH, McKeith IG, Piggott MA, Smith P, Marshall E. Clinical, pathological and neurochemical characteristics of Lewy body dementia. In: Alzheimer's and Parkinson's Diseases: Recent Developments. Springer US, 1995, pp.77-86.
- Davis M, Mendelow AD, Perry RH, Chambers IR, James OFW. The Effect of Age on Cerebral Oedema, Cerebral Infarction and Neuroprotective Potential in Experimental Occlusive Stroke. In: Brain Edema IX. Vienna: Springer, 1994, pp.282-284.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. Prognostic significance of p53 over-expression in primitive neuroectodermal tumours. In: Simone, JV et al, ed. Year book of Oncology. Mosley - Year Book Inc, 1994, pp.123-1234.
- Perry EK, Court JA, Piggott MA, Perry RH. Cholinergic component of dementia and aging. in Dementia and Normal Aging. In: Huppert, FA; Brayne, C; O'Connor, DW, ed. Dementia and Normal Aging. Cambridge: Cambridge University Press, 1994, pp.437-469.
- Perry EK, Perry RH. Definition of Alzheimer's disease with Reference to Lewy Body Dementia. In: Calne, DB, ed. Advances in Neurodegeneration Research. Boston, 1993, pp.97-106.
- Perry RH. Coronal Map of Brodmann Areas in the Human Brain. In: Roberts, GW; Leigh PN, ed. Neuropsychiatric Disorders. London: Wolfe, 1993, pp.1-10.
- Perry EK, Perry RH, Marshall E, Cheng A, Edwardson JA. Neurodegenerative changes in aging and dementia: a comparison of Alzheimer and Lewy Body type pathology. In: Kznevik, S; Kostovic I, ed. Neurodevelopment, Aging and Cognition. Boston: Birkhauser, 1992, pp.199-214.
- Perry EK, Perry RH. Neuroanatomical aspects of cognitive dysfunction in human brain. In: Prospects in Aging - Sandoz Lectures in Gerontology. Academic Press Ltd, 1992, pp.128-152.
- McKeith IG, Perry RH, Fairbairn AF, Perry EK. Delusions and hallucinations in senile dementia of Lewy body type. In: Heterogenite de la maladie D'Alzheimer. Marseille: Fondation Ipsen, 1992, pp.123-1234.
- Perry E, Court J, Whiting P, Edwardson J, Hughes D, Barlow R, Perry R. Role of the Nicotinic Receptor in Dementia. Biological Psychiatry. In: Racogni, G, ed. Biological Psychiatry. Amsterdam: Elsevier Science Publishers, 1991, pp.820-824.
- Perry RH, Perry EK. Les Modifications Neurochimiques Pathologiques qui Surviennent dans le Cerveau lors du Vieillissement et au Cours des Démences. In: Lamour, Y, ed. Le vieillissement cérébral, Nouvelle Encyclopédie Diderot. Paris: Presses Universitaires de France, 1990, pp.113-157.
- Perry EK, Perry RH, Xuereb JH, Irving D, Blessed G, Fairbairn AF, Cross AJ. Noradrenergic and Cholinergic Innervation of the Cortex in Ageing and Dementia. In: Liss, AR, ed. Progress in Catecholamine Research. 187-192, 1988.
- Perry EK, Smith CJ, Keith AB, Xuereb JH, Perry RH. Cholinergic Neuropathology and Nicotinic Receptor Binding in the Human Brain. In: (NATA advanced research workshop), ed. Nicotinic acetylcholine receptors in the Nervous System. Springer Verlag, 1988, pp.351-365.
- Perry EK, Perry RH. Aging and Dementia: Neurochemical and Neuropathological Comparisons. In: Henderson, AS; Henderson, JH, ed. Etiology and Dementia of Alzheimer's Type. Dahlem: John Wiley & Sons Ltd, 1988, pp.213-228.
- Ferrier IN, McKeith IG, Charlton BG, Whitford CA, Marshall E, Perry RH, Eccleston D, Edwardson JA. Postmortem Investigation of Serotonergic and Peptidergic hypothesis of Affective Illness. In: Lever, B; Gershon, S, ed. New Directions in Affective Disorders. Berlin: Springer Verlag, 1987.
- Wang JX, Roeske WR, Mei L, Malatynska E, Wang W, Perry EK, Perry RH, Yamamura HI. Nicotinic and Muscarinic M2 Receptor Alterations in the Cerebral Cortex of Patients with Senile Dementia of the Alzheimer's Type. In: Rand, H; Raper, C, ed. Pharmacology. Amsterdam: Elsivier, 1987, pp.83-86.
- Wang JX, Gulya K, Vickroy TW, Watson M, Hei L, Roeske WR, Perry EK, Perry RH, Fibiger HC, Yamamura HI. Alterations of Cholinergic and Somatostatin Systems in Alzheimer's Disease and its Animal Models. In: Alzheimer's Disease and its Animal Models 3rd Tokyo Symposium, Liver and Aging. 1987, pp.209-220.
- Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. In: D.F. Swaab, E. Fliers, M. Mirmiran, W.A. Van Gool and F. Van Haaren, ed. Aging of the Brain and Alzheimer's Disease. Amsterdam; Oxford: Elsevier, 1986, pp.105-132.
- Edwardson JA, Perry RH, Candy JM, Oakley AE, Perry EK. Structural and Chemical aspects of Cortical Pathology in Alzheimer's Disease. In: Fisher, A; Hanin I; Lachman, C, ed. Advances in Behavioural Biology: Alzheimer's and Parkinson's Diseases. New York: Plenum Press, 1986, pp.543-52.
- Gulya K, Watson M, Vickroy TW, Roeske WR, Perry RH, Perry EK, Duckles SP, Yamamura H. Examination of Cholinergic and Neuropeptide Receptor alterations in Senile Dementia of the Alzheimer's type (SDAT). In: Fisher, A; Hanin I; Lachman, C, ed. Advances in Behavioural Biology. New York: Plenum Press, 1986, pp.109-123.
- Bateman DE, Candy JM, Perry RH, Edwardson JA. An Autoradiographic Approach for Studying the Distribution of Neurotransmitter Receptor Binding sites on Biopsy Samples of Human Gliomas. In: Walker, MD; Thomas, DGT, ed. Biology of Brain Tumours. Dordrecht: Martinus Nijhoff, 1986, pp.203-209.
- Candy JM, Oakley AE, Watt F, Grime GW, Klinowski J, Perry RH, Edwardson JA. A role for Aluminium, Silicon and Iron in the Genesis of Senile Plaques. In: Courtois, Y; Forette, B; Knook, D, ed. Modern Trends in Aging Research. London: John Libbey Eurotext Limited, 1986, pp.443-450.
- Candy JM, Edwardson JA, Klinowski J, Oakley AE, Perry EK, Perry RH. Co‑localization of Aluminium and Silicon in Senile Plaques: Implications for the Neurochemical Pathology of Alzheimer's Disease. In: Traber, J; Gispen, WH, ed. Senile Dementia of the Alzheimer Type. Berlin: Springer Verlag, 1985, pp.183-197.
- Edwardson JA, Bloxham CA, Candy JM, Oakley AE, Perry RH, Perry EK. Alzheimer's Disease and Parkinson's Disease: Pathological and Biochemical Changes Associated with Dementia. In: Iversen, SD, ed. Psychopharmacology: Recent Advances and Future Prospects. Oxford: Oxford University Press, 1985, pp.131-145.
- Perry RH. Neuropathology of Dementia. In: Pearce, JMS, ed. Dementia: A Clinical Approach. Oxford: Blackwell Scientific Publications, 1984, pp.89-116.
- Bloxham CA, Perry EK, Perry RH, Oakley AE, Edwardson JA, Candy JM. Neuropathological and Neurochemical Correlates of Alzheimer‑type and Parkinsonian Dementia. In: Wurtman, R; Corkin, SH; Growdon, JH, ed. Alzheimer's Disease: Advances in Basic Research and Therapies. Center for Brain Sciences and Metabolism Charitable Trust, 1984, pp.39-52.
- Perry RH, Perry EK. Neurochemical Pathology of Alzheimer's Disease - The Cholinergic Concept. In: Kay, DW; Burrows, G, ed. Handbook of Studies on Psychiatry and Old Age. Amsterdam: Elsevier Science Publishers, 1984, pp.119-132.
- Candy JM, Perry RH, Perry EK, Edwardson JA. Microanatomical Chemistry of the Human Post‑Mortem bBain. In: Knook, DL; Calderini, G; Amaducci, L, ed. Topics in Aging Research in Europe. Eurage, 1984, pp.103-111.
- Perry RH, Perry EK. Implications of Neuropathological and Neurochemical Abnormalities in Alzheimer's Disease. In: Knook, DL; Caderini, G; Amaducci, L, ed. Topics in Aging Research in Europe. Leiden: Eurage, 1984, pp.59-64.
- Candy JM, Perry RH, Perry EK, Biggins JA, Thompson JE, Irving D. Transmitter Systems in Alzheimer's Disease. In: Gispen WH; Traber, J, ed. Aging of the Brain. Amsterdam: Elsevier Science Publishers, 1983, pp.29-48.
- Perry RH, Candy JM, Perry EK. Some Observations and Speculations Concerning the Cholinergic System and Neuropeptides in Alzheimer's Disease. In: Terry, RD; Katzman, R, ed. Biological Aspects of Alzheimer's Disease. New York: Cold Spring Harbor Laboratory, 1983, pp.351-361.
- Perry EK, Perry RH. Acetylcholinesterase in Alzheimer's Disease. In: Reisberg, B, ed. Alzheimer's Disease: the Standard Reference. New York: The Free Press, 1983, pp.93-99.
- Perry RH, Perry EK. The Ageing Brain and its Pathology. In: Levy, R; Post, F, ed. The Psychiatry of Late Life. Oxford: Blackwell Scientific Publications, 1982, pp.9-67.
- Perry EK, Perry RH. Cortical Neurotransmitter and Neuropeptide Activities in Alzheimer's disease. In: Perris, C; Struwe, G; Jansson, B, ed. Biological Psychiatry. Amsterdam: Elsevier/North Holland Biomedical Press, 1981, pp.961-964.
- Perry EK, Perry RH. Brain Biochemistry in Dementia of Alzheimer‑type. In: Clifford Rose, F, ed. Metabolic Disorders of the Nervous System. Bath: The Pitman Press, 1981, pp.382-417.
- Perry EK, Perry RH. The cholinergic system in Alzheimer's disease. In: PJ Roberts, ed. Biochemistry of Dementia. Chichester: John Wiley & Sons Ltd, 1980, pp.135-183.
- Perry RH, Perry EK. Histochemistry of Brain Cholinesterases in Normal Old Age and Alzheimer's disease. In: Amaducci, A; Davison, A; Antuono, P, ed. Aging of the Brain and Dementia. New York: Raven Press, 1980, pp.105-110.
-
Conference Proceedings (inc. Abstracts)
- Slatter M, Windebank K, Angus B, Dildey P, Barborie A, Perry R, Lester T, Norbury G, Abinun M, Flood TJ, Cant AJ, Gennery AR. Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency. In: 13th Meeting of the European Society for Immunology. 2008, Theater aan de Parade, 's-Hertogenbosch, the Netherlands: Clinical and Experimental Immunology: Wiley-Blackwell.
- Mukaetova-Ladinska EB, Andras A, Milne J, Borr I, Jaros E, Perry R, McKeith IG, Honer WG, Jakes R, Cleghorn A, Doherty J, McIntosh G, Perry EK. Loss of synaptic proteins and choline acetyltransferase in primary and secondary visual cortex in dementia with Lewy bodies. In: 109th Meeting of the British Neuropathological Society. 2008, London: Neuropathology and Applied Neurobiology: Wiley-Blackwell Publishing Ltd.
- Aarsland D, Andersen K, Larsen JP, Perry R, Larsen TW, Lolk A, Kragh-Sorensen P. Rate of cognitive decline in PD. In: International Symposium on Dementia in Parkinson's Disease. 2006, Salzburg, Austria: Journal of the Neurological Sciences: Elsevier.
- Piggott MA, Ballard CG, Perry RH, Perry EK. D2 receptors in thalamus and cortex in Parkinson's disease dementia (PDD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB). In: International Symposium on Dementia in Parkinson's Disease. 2006, Salzburg, Austria: Journal of the Neurological Sciences: Elsevier.
- Perry EK, Ziabreva I, Tasker A, Teaktong T, Pimlott S, Piggott MA, Court JA, Sayin H, Emre M, Perry RH, Ballard CG, McKeith IG. Cholinergic pathology in Lewy body dementia. In: International Symposium on Dementia in Parkinson's Disease. 2006, Salzburg, Austria: Journal of the Neurological Sciences: Elsevier.
- Mahad DJ, Baker M, Thomas L, Goonetileke A, Walls TJ, Perry R, Reid M. Immunotyping of cerebrospinal fluid lymphocytes by flow cytometry in primary central nervous system B-cell lymphoma. In: Immunology: Annual Congress of the British Society for Immunology. 2005, Harrogate, UK: Wiley-Blackwell Publishing Ltd.
- Religa D, Johnson M, Kalaria R, Jaros E, McKeith IG, Perry R, Court JA, Naslund J, Perry EK. Decreased levels of amyloid beta peptide in the brains of smokers. In: European Journal of Neurology: 9th Congress of the EFNS. 2005, Athens, Greece: Wiley-Blackwell Publishing Ltd.
- Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. In: 1st Congress of the International Society for Vascular Behavioural and Cognitive Disorders (VAS-COG 2003). 2004, Goteborg, Sweden: Journal of the Neurological Sciences: Elsevier.
- Betts J, Jaros E, Perry R, Schaefer A, Barron M, Cottrell D, Borthwick G, Lightowlers R, Turnbull D. The neuropathology of mitochondrial DNA disorders. In: Biochimica et Biophysica Acta: Bioenergetics. 6th European Meeting on Mitochondrial Pathology (Euromit 6). 2004, Nijmegen, Netherlands: Elsevier BV.
- Perry EK, Perry RH. Neurochemistry of consciousness: cholinergic pathologies in the human brain. In: Acetylcholine in the Cerebral Cortex. 2004, Montreal, Canada: Academic Press.
- Cairns NJ, Zhukareva V, Uryu K, Bigio E, Makenzie IR, Geaing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM, Trojanowski JQ. alpha-internexin is present in the hallmark lesions of neuronal intermediate filament inclusion disease. In: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, PA: Neurobiology of Aging: Elsevier.
- Lana M, Moore PB, Kay DW, Berney TP, Morris C, Perry R, Tyrer SP. Age-specific incidence of dementia, clinico-pathological relationships and apolipoprotein E status in an 18-year follow up of 92 adults with Down's Syndrome (DS). In: 12th World Congress of IASSID. 2004, France: Journal of Intellectual Disability Research: Wiley-Blackwell.
- Cottrell DA, Schaefer A, Borthwick GM, Perry R, Turnbull DM. Neuronal apoptosis occurs in patients with mitochondrial DNA disorders. In: Journal of Neurology, Neurosurgery and Psychiatry: Joint Congress of the Association of British Neurologists/Neurological Association of South Africa. 2003, Cape Town, South Africa: BMJ Group.
- Johnson M, Court J, Perry E, Kalaria R, McKeith I, Jaros E, Perry R, Naslund J, Religa D. Tobacco use is associated with attenuation of beta-amyloidosis in hippocampus and entorhinal cortex of normal elderly individuals. In: Neurobiology of Aging. 2002, Elsevier Inc.
- Thomas AJ, Perry R, Barber R, Kalaria RN, O'Brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. In: Annals of the New York Academy of Sciences. 2002, Kyoto, Japan: Wiley-Blackwell Publishing.
- Thomas AJ, Perry R, Barber R, Kalaria RN, O'Brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. In: Alzheimer's Disease: Vascular Etiology and Pathology. 2002, Kyoto, Japan: New York Academy of Sciences.
- Teaktong T, Graham A, Court J, Johnson M, Hall R, Perry E, Perry R, Jaros E. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: Increased alpha 7 immunoreactivity of astrocytes in Alzheimer's disease. In: Neurobiology of Aging. 2002, Elsevier Inc.
- Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Jaros E, Perry RH. Cholinergic and monoaminergic correlates of clinical symptoms in dementia with Lewy bodies. In: Mapping the Progress of Alzheimer's and Parkinson's Disease. 2002, Kyoto, Japan: Springer.
- Kalaria R, Teahan O, Slade J, Thomas A, Kenny RA, Ince P, Perry R, Ballard C. Characterisation of white matter pathology in vascular dementia and Alzheimer's disease. In: Neurobiology of Aging. 2002, Elsevier Inc.
- Tyrer SP, Margallo-Lana ML, Moore PD, Kay DW, Perry RH, Berney TP, Morris C. Factors associated with cognitive decline in Down syndrome. In: 11th World Congress of the International Association for the Scientific Study of Intellectual Disabilities (IASSID). 2000, Seattle, Washington, USA: John Wiley & Sons.
- McKeith IG, Perry EK, Perry RH, and for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop - Diagnosis and treatment. In: Second International Workshop of the Consortium on Dementia with Lewy Bodies. 1999, Newcastle upon Tyne.
- Perry E, Grace J, Perry R, McKeith I. Cholinergic mechanisms of psychosis and clinical efficacy of cholinergic drugs. In: 40th Annual Meeting of the Scandinavian Society for Psychopharmacology. 1999, Copenhagen, Denmark: Informa Healthcare.
- Perry R, McKeith I, Perry E. Lewy body dementia - clinical, pathological and neurochemical interconnections. In: Dementia in Parkinsonism: Meeting of the European Brain Bank Network. 1997, London: Springer Wien.
- Perry EK, Court JA, Lloyd S, Johnson M, Griffiths MH, Spurden D, Piggott MA, Turner J, Perry RH. β-Amyloidosis in normal aging and transmitter signaling in human temporal lobe. In: Neurobiology of Alzheimer's Disease. 1996, Wiley-Blackwell Publishing, Inc.
- Davis M, Perry RH, Mendelow AD. The Effect of Non-Competitive N-Methyl-D-Aspartate Receptor Antagonism on Cerebral Oedema and Cerebral Infarct Size in the Aging Ischaemic Brain. In: Brain Edema X : Proceedings of the Tenth International Symposium. 1996, San Diego, California: Springer.
- Scoones DJ, Ince PG, Perry EK, Perry RH. Optimal brain banking: The Newcastle experience. In: 92nd Meeting of the British Neuropathological Society. 1996, Queen's University, Belfast: Wiley-Blackwell.
- Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, Lamb H, Brown A, Ince PG, Tyrer S, Thompson P, McKeith IG, Edwardson JA, Perry RH, Perry EK. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. In: Meeting on New Trends in the Diagnosis and Therapy of Non-Alzheimer's Dementia. 1996, Vienna, Austria: Springer Wien.
- Ince PG, Lowe J, Jaros E, Perry RH. Consensus criteria for the pathological evaluation of dementia with Lewy bodies. In: Proceedings: 92nd Meeting of the British Neuropathological Society. 1996, Belfast: Wiley-Blackwell Publishing Ltd.
- Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Ragbavan R, Khin-Nu C, Tyner S, Day K, Crook R, Hardy J, Roberts GW. ApoE2 allele, Down's syndrome, and dementia. In: Neurobiology of Alzheimer's Disease. 1996, Wiley-Blackwell Publishing, Inc.
- Raghavan R, Ince PG, Perry RH. Ubiquitinated Dot-Profiles (UDP) are decreased in the hippocampus in Alzheimer's disease compared with Lewy body dementia, Parkinson's disease, and controls. In: Fourth International Conference on Alzheimer's Disease and Related Disorders. 1994, Minneapolis, Minnesota, USA: Elsevier B.V.
- Ince PG, Harrington CR, Wischik CM, Raghavan R, Perry EK, Perry RH. Cortical tau-protein and neurofibrillary tangles in lewy body dementia, alzheimers-disease, parkinsons-disease and controls. In: Fourth International Conference on Alzheimer's Disease and Related Disorders. 1994, Minneapolis, MN: Elsevier Inc.
- Court JA, Perry EK, Lloyd S, Johnson M, Piggott MA, Perry RH. Both Nicotinic and alpha-Bungarotoxin Receptors are lost from the Human Hippocampal Formation during Aging in particular from the Entorhinal Cortex. In: Brain Research Abstr. 1994.
- Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the Developing and Senescent Human Brain. In: Alzheimer's Disease: Amyloid Precursor Proteins, Signal Transduction, and Neuronal Transplantation. 1993.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. Poor prognosis in primitive neuroectodermal tumours is associated with p53 mutation and over-expression. In: British Paediatric Association, 1993 Warwick. 1993.
- Piggott MA, Perry EK, Perry RH, Court JA. Polyamine modulation of (3H)MK-801 binding to the NMDA receptor in frontal cortex during human development. In: Brain Research Association Abstracts. 1993.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. p53 protein expression and gene mutation in relation to prognosis in primitive neuroectodermal tumours. In: Proceedings of the American Association for Cancer Research. 1993.
- Jaros E, Lunec J, Perry RH, Pearson ADJ. p53 over-expression are indicators of poor prognosis in primitive neuroectodermal tumours. In: 3rd International Neuro-Oncology conference. 1993.
- McKeith IG, Perry RH, Perry EK, Fairbairn AF. Clinical Features of Lewy body dementia. In: Proceedings Annual Meeting American Psychiatric Association. 1993.
- Raghaven R, Irving D, Brown A, Ince IG, Perry RH. Lewy Body Prevalence in Parkinson's Disease, Senile Dementia of Lewy body Type, and the normal elderly. In: Proceeding of the Spanish and British Neuropathogical Society. 1992.
- McKeith IG, Fairbairn AF, Perry EK, Perry RH. Clinical characteristics of Lewy body dementia in the elderly. In: Proceedings 5th Congress International Psychogeriatric Association. 1992.
- Perry RH, Smith PEN, Fairbairn AF, Perry EK, McKeith IG. Causes of dementia in the elderly and the spectrum of Lewy body disorders. In: Proceedings 5th Congress International Psychogeriatric Association. 1992.
- Lown OP, Cheng AVT, Keith AB, Lloyd S, Perry EK, Perry RH, Sahgal A, Ferrier IN. Serotonergic and Cholinergic lesions: effects on Memory and Neurochemistry. A model of Dementia?. In: Serotonin Meeting. 1991, Birmingham.
- Gilbertson RJ, Pearson ADJ, Jaros EB, Perry RH. Immunohistochemical Studies of c-erb B2 labelling and Mitotic Index in Childhood PNET (Primitive Neuroectodermal Tumours). In: Neuropathology and Applied Neurobiology British Neuropathological Society. 1991.
- Irving D, Perry RH, Perry EK, Xuereb JH, Fairbairn AF, Dick DJ. Morphological aspects of the Nucleus Basalis of Meynert in Dementia. In: Leipzig Worksop on the Meynert Nucleus. 1987, Leipzig.
- HedleyWhyte ET, Perry RH, Candy JM, Edwardson JA. Ultrastructure of Immunoreactive Substance P in Human and Marmoset Rostral Substantia Innominata. In: Society of Neuroscience Abstracts. 1986.
- Whitford CA, Smith CJ, Candy JM, Edwardson JA, Perry RH. Hippocampal somatostatin receptors in human cognitive disorders. In: Bayliss & Starling Society National Scientific Meeting. 1986, Liverpool, UK: Elsevier BV.
- PERRY RH, OAKLEY AE, CANDY JM, EDWARDSON JA, PERRY EK. ELEMENTAL ANALYSIS OF ISOLATED AND INSITU SENILE PLAQUE CORES. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1985.
- Gulya K, Vickroy TW, Watson M, Roeske WR, Perry EK, Perry RH, Duckles SO, Yamamura HI. Cholinergic and Somatostatinergic Receptor Alterations in Senile Dementia of the Alzheimer's type (SDAT) and in its Animal Model. In: Society of Neuroscience Abstracts. 1985.
- Edwardson JA, Oakley AE, Klinowski J, Perry RH, Perry EK, Candy JM. Aluminosilicates and the Genesis of Senile Plaques. In: society of Neuroscience Abstracts. 1985.
- Candy JM, Perry RH. Immunocytochemical Localisation of Neuropeptides in the Nucleus of Meynert and Adjacent Regions of the Human Brain. In: Regulation of transmitter Function: Basic and Clinical Aspects. 1984, Budapest: Euronean Society Neurochemistry.
- Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. In: Bayliss & Starling Society National Scientific Meeting. 1983, Newcastle upon Tyne: Elsevier BV.
- Biggins JA, Perry RH, Candy JM, Perry EK, Bloxham CA, Johnson M, Edwardson JA. Neurotensin immunoreactivity and choline acetyltransferase activity in the cerebral cortex in Parkinson's disease. In: Bayliss & Starling Society National Scientific Meeting. 1983, Newcastle upon Tyne: Elsevier BV.
- Davies RR, Ferner RE, Perry RH, McGill A, Strong AJ, Gosh SK, Tunbridge WMG. TSH Secreting Pituitary Tumour. In: 1st Joint Meeting British Endocrine Societies. 1982.
- Blessed G, Crow TJ, Cross AJ, Perry EK, Perry RH, Tomlinson BE. Monoaminergic Function in Postmortem Brain in Depression. In: 13th CINP Congress. 1982, Jerusalem, Israel.
- Candy JM, Perry RH, Perry EK, Oakley A, Smith I, Edwardson JA. Factors influencing the formation and stability of substance P fibrillary polymers. In: Bayliss and Starling Society National Scientific Meeting. 1982, London: Elsevier BV.
- Boakes RJ, Candy JM, Ednie J, Perry RH, Oakley A, Edwardson JA. Effects of substance P in the hippocampal slice preparation - Activity of substance P and substance P fibrillary polymers. In: Bayliss and Starling Society National Scientific Meeting. 1982, London: Elsevier BV.
- Perry RH, Candy JM, Thompson J, Woods M, Oakley A, Edwardson JA. A major peptidergic tract in the human brain - Relationship to stria terminalis and anterior commissure. In: Bayliss and Starling Society National Scientific Meeting. 1982, London: Elsevier BV.
- Hardy JA, Dodd PR, Oakley AE, Perry RH, Edwardson JA. Metabolically Active Synaptosomes can be isolated from Frozen Homogenates of Human Brain. In: Abstracts of the Eighth Meeting of the International Society for Neurochemistry. 1981.
- Candy JM, Oakley AE, Perry EK, Perry RH. Existence in vitro of fibrillary aggregates of substance P, cholecystokinin octapeptide, somatostatin and related molecules. In: Proceedings of the Physiological Society. 1981, Wiley-Blackwell Publishing Ltd.
- Candy JM, Oakley AE, Perry EK, Perry RH. Electron-microscopic demonstration of fibrillary forms of small peptides common to brain and gut. In: Proceedings of the Physiological Society. 1981, Wiley-Blackwell Publishing Ltd.
- Candy JM, Perry RH, Perry EK, Thompson JE. Distribution of Putative Cholinergic Cell Bodies and Various Neuropeptides in the Substantia Innominata Region of the Human Brain. In: Journal of Anatomy. 1981.
- Ward MK, Pierides AM, Fawcett P, Shaw DA, Perry RH, Tomlinson BE, Kerr DNS. Dialysis encephalopathy syndrome. In: European Dialysis and Transplant Association. 1976, Hamburg, Federal Republic of Germany: Nature Publishing Group.
- Ramani PS, Perry RH, Tomlinson BE. Role of ligamentum flavum in the symptomatology of prolapsed lumbar intervertebral discs. In: Proceedings of The Forty-Ninth Meeting Of The British Neuropathological Society Held Jointly With The Swiss Association For Neuropathology. 1975, Newcastle upon Tyne: Wiley-Blackwell Publishing Ltd.
-
Editorials
- Perry EK, Irving D, Perry RH. New links between Alzheimer's and Parkinson's disease. Alzheiers Disease Society 1994, 8, 6.
- Perry EK, Perry RH. New insights into the nature of senile (Alzheimer-type) plaques. Trends in Neurosciences 1985, 8(7), 301-303.
-
Letters
- Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Elderly Individuals With FTLD [Reply]. JAMA Neurology 2013, 70(3), 412-413.
- Baborie A, Jaros E, Griffiths TD, Momeni P, Perry R, Mann DMA. Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes. Neuropathology and Applied Neurobiology 2012, 38(1), 101-104.
- Kalaria RN, Perry RH, O'Brien J, Jaros E. Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathology and Applied Neurobiology 2012, 38(5), 505-508.
- Busby J, O'Brien KK, Gibson AM, McKeith IG, Perry RH, Hardy JA, Singleton AB, Morris CM. Dementia with Lewy bodies: No association of polymorphisms in the human synphilin gene. Neurogenetics 2004, 5(4), 251-252.
- Stone J, Griffiths TD, Rastogi S, Perry RH, Cleland PG. Non-picks frontotemporal dementia imitating schizophrenia in a 22-year-old man [8]. Journal of Neurology 2003, 250(3), 369-370.
- O'Brien JT, Thomas A, English P, Perry R, Jaros E. A prospectively studied clinicopathological case of 'vascular depression'. International Journal of Geriatric Psychiatry 2003, 18(7), 656-657.
- Perry E, Walker M, Perry R. Consciousness in mind: a correlate for ACh? Reply to Hölscher. Trends in Neurosciences 1999, 22(12), 542-543.
- Perry EK, Kerwin JM, Perry RH. On neuronal ill health. Trends in Neurosciences 1994, 17(2), 51-51.
- Piggott MA, Perry EK, McKeith IG, Marshall E, Perry RH. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994, 343(8904), 1045-1045.
- Gilbertson RJ, Jaros EAB, Perry RH, Pearson ADJ. Prognostic factors in medulloblastoma. The Lancet 1992, 340(8817), 480.
- Perry EK, Irving D, Perry RH. Cholinergic Controversies. Trends in Neurosciences 1991, 14(11), 483-484.
- Perry EK, Kerwin J, Perry RH, Blessed G, Fairbairn AF. Visual hallucinations and the cholinergic system in dementia. Journal of Neurology, Neurosurgery and Psychiatry 1990, 53(1), 88-88.
- Narang HK, Perry RH. Diagnosis of Creutzfeldt-Jakob disease by electron microscopy. Lancet 1990, 335(8690), 663-664.
- Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Senile dementia of Lewy body type and spectrum of Lewy body disease. Lancet 1989, 1(8646), 1088-1088.
- Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet 1989, 1(8630), 165-166.
- Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(3), 356-356.
- Cross AJ, Slater P, Candy JM, Perry EK, Perry RH. Glutamate deficits in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(3), 357-358.
- Uney JB, Marchbanks RM, Reynolds GP, Perry RH. Lithium prophylaxis inhibits choline transport in post-mortem brain. Lancet 1986, 2(8504), 458-458.
- Perry RH, Tomlinson BE, Candy JM, Blessed G, Foster JF, Bloxham CA, Perry ER. Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet 1983, 2(8353), 789-790.
- Perry RH, Wilson ID, Bober MJ, Atack J, Blessed G, Tomlinson BE, Perry EK. Plasma and erythrocyte acetylcholinesterase in senile dementia of alzheimer type. Lancet 1982, 319(8264), 174-175.
- Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TT. Noradrenergic and cholinergic systems in senile dementia of alzheimer type. Lancet 1981, 318(8238), 149-149.
- Perry EK, Blessed G, Perry RH, Tomlinson BE. Brain Biochemistry in Schizophrenia. LANCET 1978, 1(8054), 35-36.
- Perry RH, Tomlinson BE, Taylor MJ, Perry EK. Human Brain Temperature at Necropsy: a Guide in Postmortem Biochemistry. Lancet 1977, 1(8001), 38-38.
- Perry EK, Perry RH, Tomlinson BE. Dietary Lecithin supplements in Dementia of Alzheimer Type?. Lancet 1977, 2(8031), 242-243.
- Perry EK, Perry RH, Taylor MJ, Tomlinson BE. Circadian Variation in Human Brain Enzymes. Lancet 1977, 2(8014), 753-754.
- Weller M, Perry RH. Unusual Cardiac and Neurological Reactions to Narcotics. Lancet 1973, 2(7832), 799-800.
- Perry RH. Electrocardiogram and Hard Drugs. Lancet 1973, 1(7818), 1509-1509.
-
Notes
- McKeith IG. Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2018, 90(6), 301-301.
- Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK. Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging 2006, 27(3), 433-438.
- Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH. Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia. Journal of Neurochemistry 1990, 55(4), 1454-1456.
- Johnson M, Perry RH, Charlton FG, Moses MA, Court JA, Perry EK. Distribution of [3H]MK801 binding in the normal aged human hippocampus. Brain Research 1989, 499(1), 184-187.
- Bateman DE, McDermott JR, Perry RH, Dimaline R, Biggins JA, Edwardson JA. Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma. Journal of Neurology, Neurosurgery and Psychiatry 1986, 49(9), 1074-1076.
- Perry EK, Perry RH. CNS cholinergic markers and Alzheimer's disease. Neurobiology of Aging 1986, 7(5), 390-391.
- Tarbit I, Perry EK, Perry RH, Blessed G, Tomlinson BE. Hippocampal Free Amino Acids in Alzheimer's Disease. Journal of Neurochemistry 1980, 35(5), 1246-1249.
- Perry EK, Perry RH, Taylor MJ, Tomlinson BE. Evidence of a circadian fluctuation in neurotransmitter enzyme activities measured in autopsy human brain. Journal of Neurochemistry 1977, 29(3), 593-594.
-
Reviews
- McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017, 89(1), 88-100.
- McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 2005, 65(12), 1863-1872.
- Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK. Attenuation of A beta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. Neuropathology and Applied Neurobiology 2005, 31(5), 522-535.
- Martin-Ruiz CM, Piggott M, Gotti C, Lindstrom J, Mendelow AD, Siddique MS, Perry RH, Perry EK, Court JA. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease. Neuropharmacology 2000, 39(13), 2830-2839.
- Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999, 122(8), 1449-1468.
- Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends in Neurosciences 1999, 22(6), 273-280.
- Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJM, Piggott MA, Oakley AE, Ince PG, Perry EK, Perry RH. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Developmental Brain Research 1997, 101(1-2), 93-105.
- McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, MIrra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, deVos RAI, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996, 47(5), 1113-1124.
- Perry EK, Perry RH. Human brain neurochemistry - Some postmortem problems. Life Sciences 1983, 33(18), 1733-1743.